Analysis of Coxiella Burnetii Mediated Modulation of Host Cells During Infection by Mahapatra, Saugata
ANALYSIS OF COXIELLA BURNETII 






Master of Science in Microbiology 






Submitted to the Faculty of the 
Graduate College of the 
Oklahoma State University 
in partial fulfillment of 
the requirements for 
the Degree of 
DOCTOR OF PHILOSOPHY 
July, 2011 
 ii 
ANALYSIS OF COXIELLA BURNETII 








Dr. Edward I. Shaw 
Dissertation Adviser 
 
Dr. David K. Burnham 
 
Dr. William D. Picking 
 
Dr. Jeffrey A. Hadwiger 
 
Dr. Susan E. Little 
 
Dr. Patricia Canaan 
 
Dr. Mark E. Payton 





It would not have been possible to pursue and complete this doctoral study 
without the guidance and the help of several individuals who in one way or another 
contributed and extended their valuable assistance in its preparation and completion. 
First, my utmost gratitude to my parents, my elder brother and his family who 
have been pillars of support and provided me the strength to go on at times when I really 
felt low.  They taught me that the best kind of knowledge to have is that which is learned 
for its own sake.  The mere expression of thanks does not suffice the endless support that 
I have always received from home. 
I am most grateful to Shaw lab members; Dr. John Kent Morgan, and Brandon 
Luedtke, for promoting a stimulating academic as well as sociable environment at work.  
The good advice, support and friendship will be thoroughly missed.  Not forgetting Anu, 
Brian, Lawnie, Luisa, Shom, and other friends who have always been there.  
I would like to acknowledge Dr. Dan Stein, and Mr. Rod Mills for technical 
advice and direction in performing microarrays.  I also thank the members of my 
graduate committee for their guidance and suggestions.  Special thanks to the Department 
of Microbiology for the use of facilities, consultations, encouragement and financial 
assistance. 
Last but not the least I want to thank my advisor Dr. Edward I. Shaw who taught 
me with great care and detail, the science behind obligate intracellular pathogenesis.  His 
sage advice, insightful criticisms, patient encouragement and immense knowledge has 
immeasurably aided in the completion of this study.  Dr. Shaw, I deeply appreciate the 
invaluable assistance that I received from you on both academic and personal levels.  In 
hindsight, I believe I could not have imagined having a better advisor and mentor for my 
PhD study. 
 iv 
TABLE OF CONTENTS 
 
 
Chapter          Page 
 
I.  INTRODUCTION:  SCOPE OF STUDY AND ABSTRACT ................................1 
  
 Abstract ....................................................................................................................8 
 
II.  LITERATURE REVIEW ......................................................................................10 
  
 Coxiella burnetii:  Introduction .......................................................................11 
 Coxiella burnetii:  Brief history of discovery ..................................................11 
 Coxiella burnetii:  Epidemiology.....................................................................14 
 Coxiella burnetii:  Disease ...............................................................................17 
 Coxiella burnetii:  Cultivation .........................................................................22 
 Coxiella burnetii:  Microbiology .....................................................................24 
 Coxiella burnetii:  Intracellular lifestyle ..........................................................31 
 
III. COXIELLA BURNETII NINE MILE II PROTEINS MODULATE GENE 
EXPRESSION OF MONOCYTIC HOST CELLS DURING INFECTION   .......43 
  
 Abstract ............................................................................................................44 
 Background ......................................................................................................46 
 Methods ...........................................................................................................49 
 Results ..............................................................................................................54 
 Discussion ........................................................................................................60 
 Conclusions ......................................................................................................66 
 
IV. COXIELLA BURNETII MODULATES NF-κB ACTIVATION IN HUMAN  
 THP-1 CELLS DURING INFECTION  ................................................................76 
  
 Introduction ......................................................................................................77 
 Materials and methods .....................................................................................80 
 Results ..............................................................................................................83 
 Discussion ........................................................................................................86
 v 
chapter          page 
 
V. GROWTH OF COXIELLA BURNETII IN THE IXODES SCAPULARIS  
 DERIVED IDE8 TICK CELL LINE .....................................................................96 
  
 Abstract ............................................................................................................97 
 Introduction ......................................................................................................98 
 Materials and methods .....................................................................................99 
 Results ............................................................................................................103 
 Discussion ......................................................................................................106 
  
VI. SUMMARY REVIEW OF:  ANALYSIS OF COXIELLA BURNETII MEDIATED 





LIST OF TABLES 
 
 
Table           Page 
 
3.1   Differentially expressed host genes modulated by C. burnetii protein 
synthesis ..............................................................................................................68 
 
S1.A-I   Excel file containing Tables S1.A through S1.I as individual tab- 
accessible tables within a single file (Supplemental Table S1.A-I)....................73 
 
4.1    Temporal analysis of NF-κB activation in C. burnetii infected  




LIST OF FIGURES 
 
 
Figure           Page 
 
3.1:  Diagram of the experimental design for comparative C. burnetii infected. ........69 
 
3.2:  Phase contrast and fluorescent microscopy of C. burnetii infected  
THP-1 cells .........................................................................................................70 
 
3.3:  Venn diagram of differentially expressed THP-1 genes ......................................71 
 
3.4:  RT-qPCR of selected genes confirms microarray expression trends. .................72 
 
S1:  Biological function assignments of genes differentially expressed  
in mock and CAM treated THP-1 cells infected with C. burnetii . ......................74 
 
4.1:  Immunoblot analysis of C. burnetii modulation of host-cell  
NFκB activation. .................................................................................................93 
 
4.2:  Analysis of NFκB activation in C. burnetii infected cells  
throughout the infectious. cycle ..........................................................................94 
 
4.3:  Western blot analysis of NFκB p100 and p52 expression over  
 the time course of C. burnetii infection. ...............................................................95 
 
5.1:  IFA of Coxiella burnetii NMII infection of IDE8 cells   ...................................109 
 
5.2:  C. burnetii genome levels during infection of IDE8 cells .................................110 
 
5.3:  RT-PCR detection of C. burnetii T4BSS transcripts, icmW, icmV,  
and dotH during infection of IDE8 cells. ..........................................................111 
 
5.4:  IFA of IDE8 derived Coxiella burnetii NMII infecting Vero cells ...................112 
 
6.1:  Mechanism showing C. burnetii mediated modulation of host cell  












Coxiella burnetii is an obligate intracellular bacterium that replicates within a 
parasitophorous vacuole (PV) of the eukaryotic host cell [1-3].  C. burnetii infection can 
manifest as either an acute (Q fever) or chronic disease.  Acute Q fever is commonly a 
self-limiting flu-like illness, with symptoms ranging from sub-clinical to debilitating [4].  
The most common sequelae of chronic disease include endocarditis, hepatitis, and/or a 
chronic fatigue syndrome [5-6].  In addition, C. burnetii infection of heart valves is a 
leading cause of culture-negative endocarditis [7].  Treatment of Q fever endocarditis is 
expensive and involves a protracted 18-24 month course of antibiotics [8], and often 
requires surgical removal of the infected valve. 
The molecular mechanisms that C. burnetii uses to parasitize host cells are largely 
unknown.  After inhalation and subsequent contact with alveolar macrophages, C. 
burnetii are internalized, trafficked through the endocytic pathway, and reside within an 
acidified PV [3, 9].  Studies suggest that the virulent Nine Mile Phase I (NMI) strain 
invades a cell by an association with the host cell alpha(v)beta(3) integrin receptor while 
the avirulent Nine Mile Phase II (NMII) strain enters through an association with  
alpha(v)beta(3) integrin and Complement Receptor 3 [10-11].  Experiments show that 
Coxiella protein synthesis is directly involved in a 4-6 hour delay of phagolysosomal 
maturation with a simultaneous increase in PV fusogenicity with host vesicles that are 
specifically trafficked to the PV to produce the spacious PV (SPV) [12-13].  Once C. 
burnetii is established in the PV, they appear to direct an  expansion of the PV which 
becomes spacious in relation to the number of bacteria within the vacuole until late in 
infection [3].  While this expansion process is not well defined, it appears to be the result 
of host cell vesicles fusing with the PV through a process which requires C. burnetii 
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protein synthesis [12-13].  The PV recruits distinct markers over the course of 
endocytotic trafficking.  Less than six hours post infection, the PV acquires small 
GTPases Rab5 (early endosomal marker) and, to a lesser extent, Rab7 (late endosomal 
marker) while a mature PV maintains the characteristics of a phagolysosome.  Moreover, 
the PV is also observed to interact with autophagosomes [14-18].  By two days post 
infection, the mature PV membrane contains vacuolar H+ ATPase, Rab7, LAMP-1, -2, 
and -3, flotillin 1 and 2, LC3, and Rab24 [3, 18].  If de novo bacterial protein synthesis is 
interrupted, the SPV-specific vesicle trafficking ceases and the SPV collapses into a tight 
vesicle which eventually destroys the organism.  These studies clearly indicate that PV 
biogenesis and maintenance is regulated by C. burnetii proteins [12-13].   
In addition, C. burnetii proteins actively inhibit apoptosis.  C. burnetii infected 
macrophages treated with inducers of extrinsic and intrinsic apoptotic pathways show a 
decreased release of cytochrome c from mitochondria, a reduction in caspase activity, and 
a decline in pro-apoptotic proteolytic cleavage [19-20].  Infection also results in induction 
of pro-survival transcriptional response, including sustained Akt and Erk 1/2 (host 
kinases) activation [19, 21].  These anti-apoptotic mechanisms are lost if C. burnetii 
protein synthesis is inhibited.  These studies suggest that C. burnetii proteins actively 
mediate the manipulation of host cell processes; however, little is known about the cell 
biology mechanisms involved or whether these mechanisms might also be used by the 
pathogen during in vivo infection.  Hence, characterization of the host cell pathways 
which are specifically regulated by C. burnetii derived proteins will contribute to our 
understanding of host-pathogen interactions, provide valuable targets for intervention 
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strategies, identify virulence associated cell responses, and establish in vitro models of 
the molecular interactions of this intracellular pathogen. 
Intracelluar bacterial pathogens have evolved survival strategies that include 
bypassing the host‟s defense systems.  One key means of establishing systemic infection 
is to overcome the host cells innate immune response [22].  The fact that C. burnetii 
invade macrophages and that a subset of infection becomes chronic indicate that C. 
burnetii has the capacity to not only overcome the host cell innate immune response 
mechanisms, but also modify the immune response to infection over the long term [23].  
Macrophages are primary effector immune cells and protect the host by generating an 
innate immune response against invading pathogens.  Upon detecting a pathogen, 
Pathogen Recognition Receptors (PRRs) such as Toll like receptors (TLR) and Nod like 
receptors (NLR) trigger a cellular alarm system comprised of intrinsic response pathways 
that activate surrounding immune cells [24].  This results in an aggressive pro-
inflammatory response, phagocytosis and degradation of the pathogen, or migration of 
infected cells to secondary lymphoid tissue and subsequent antigen presentation.  Cell 
surface TLRs (TLR1-6, TLR 10, and TLR 11) and endosomal membrane TLRs (TLR3 
and TLR7–TLR9) signal through MyD88, which activates the NF-κB or IRF3-IRF7 
pathway [24-33].  Signaling may also occur through MAP kinase networks by activating 
the MAPK proteins p38, Jnk, and Erk through phosphorylation [27-29, 32, 34-35].  
Whereas MAPKs regulate gene expression through the phosphorylation of other proteins, 
NF-κB subunits bind directly to DNA to regulate transcription [27].  Hence, PRRs follow 




The role of host TLRs and the innate immune response in controlling C. burnetii 
has been investigated.  Studies indicate that host TLR-2 is needed for pathogen 
recognition and growth restriction [36].  Replication of C. burnetii is restricted in 
macrophages in response to TLR2 activation [36] while TLR2 deficient mice permit 
unrestricted growth of C. burnetii [36].  However, alternate findings have suggested that 
host TLR-4 is associated with initial pathogen uptake and localized actin polymerization 
within the host [37].  This theory is contrary to findings that demonstrate C. burnetii 
phase II to activate TLR2 but not TLR4 [36].  In addition, the LPS of virulent Phase I 
organisms, but not Phase II organisms, prevents activation of dendritic cells by masking 
the TLR-4 ligand [38], further suggesting that TLR4 is primarly affected by C. burnetii 
infection. 
Several investigations on Q fever cytokine response indicate that C. burnetii 






) form of activation in monocyte-
derived macrophages (MDM) [39].  Other experiments performed to detect pro-
inflammatory cytokines in DCs reveal that phase II C. burnetii promotes DC maturation 
and secretion of IL-12 and TNF [38, 40].  Increased productions of other pro-
inflammatory cytokines like RANTES, MCP-1 and transcriptional upregulation of 
SCYA3, SCYA4, and IL-8 chemokines has also been detected [41-42].  In addition, the 
studies on apoptosis during C. burnetii infection demonstrated an upregulation of genes 
involved in NFκB signaling as well as an increase in the expression of c-iap2 and A1/bfl-
1, antiapoptotic proteins that are positively regulated by NFκB transcription factors [19, 
21].  Together these studies suggest that the host innate immune system attempts to 
restrict C. burnetii infections.  However, none of these studies indicate how C. burnetii 
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interferes and subverts the signaling pathways of the immune response and establishes a 
productive infection. 
The ability of C. burnetii to survive within macrophages while avoiding host 
immune response and modulating the cellular processes at the molecular level requires 
the skill to deliver effector molecules out of the PV [3, 18, 23].  The C. burnetii type IV 
secretion system (T4SS) represents a means for the bacteria to deliver effector proteins 
into the host during the initial infection as well as subsequent PV establishment and 
bacterial growth, allowing for its survival and cellular pathogenesis.  Generally, multiple 
intracellular pathways might be modulated throughout the infectious cycle, whereby 
bacteria proteins interact at several points in a pathway to exploit it.  Recent studies have 
identified a list of potential C. burnetii T4SS effector proteins whose function are yet 
unknown [43-45]. 
Despite recent advances, knowledge of C. burnetii‟s targets inside a host cell is 
still limited.  In addition, C. burnetii’s ability to evade detection and grow intracellularly 
by suppression of the host‟s immune response is yet to be understood.  These properties 
represent a model for studying virulence determinants which can subsequently unravel 
specific molecular interactions of C. burnetii with its host cell.  As such, I sought to 
address the following questions: 
 Does de novo C. burnetii protein synthesis regulate host-cell gene expression 
during infection? 
 Does C. burnetii actively modulate host cell immune response?  
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Additionally, no tissue culture model exists to study host cell-pathogen 
interactions in ticks.  In nature, it is possible for domestic animals (cattle, sheep and goat) 
to acquire C. burnetii via tick bites as well as by contact with contaminated tick excreta 
[4, 46-48].  Ticks likely play a large role in the transmission of this infectious agent 
between wild and domestic animals [48].  Interestingly, more than 40 species of ticks 
have been found infected with C. burnetii [4].  Historically, crude primary tick cell 
cultures have been shown to support C. burnetii growth, but a modern, established tick 
cell line has never been employed [49].  In an attempt to develop alternate in vitro models 
of C. burnetii-host cell interactions, I sought to determine: 
 Is C. burnetii capable of infecting a modern continuous tick cell culture? 
 Does C. burnetii replicate within cultured tick cells, and at what rate? 
 Is C. burnetii produced within tick cells capable of subsequently infecting 




Coxiella burnetii is an obligate intracellular bacteria and the etiologic agent of Q 
fever.  Although discovered over six decades ago, our understanding of the molecular 
mechanisms involved in disease development remains elementary.  Few host cell 
processes actively modulated by C. burnetii have been identified.  This study analyses 
host-cell pathways and processes that are specifically affected by C. burnetii proteins.  It 
also defines C. burnetii induced temporal modulation of NF-kB activation throughout the 
infectious cycle.  Additionally, it determines C. burnetii‟s growth cycle in an established 
tick cell line.  First, the global expression of host cell mRNA was characterized following 
infection with C. burnetii Nine Mile Phase II and transient inhibition of bacterial protein 
synthesis with chloramphenicol.  Using comparative microarray analysis, 36 host cell 
genes were identified to be distinctively modulated by C. burnetii proteins.  Subsequent 
gene ontology analysis revealed expression changes in host cell functions such as innate 
immune response, cell death and proliferation, vesicle trafficking and development, lipid 
homeostasis, and cytoskeletal organization.  A subset of pro-inflammatory cytokine genes 
was also identified whose expression is classically mediated through the NF-κB signaling 
pathway.  This led to the demonstration that C. burnetii infection temporally modulates 
the activation of the NF-κB signaling pathway.  Additionally, I have shown that C. 
burnetii readily infects Ixodes scapularis-derived cultured IDE8 cells, followed by a 
prolonged lag phase, then a doubling time similar to that in eukaryotic cells.  Together 
these studies show that C. burnetii replicates and produces infectious progeny in 
arthropod cells, and temporally modulates mammalian host cell NF-κB signaling 
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Coxiella burnetii:  Introduction 
Coxiella burnetii is a Gram-negative, pleomorphic, obligate intracellular bacteria 
with a worldwide distribution [3-4].  It causes Query fever (Q fever) in humans and 
Coxiellosis in animals [4, 48, 50-51].  This is thought to be a highly underreported 
zoonotic disease and accurate estimates of global Q fever cases are unknown.  
Discovered in the late 1930‟s, C. burnetii  is taxonomically placed in the γ-subdivision of 
the phylum proteobacteria [52].  In nature, domestic animals (cattle, sheep, and goats) are 
considered to be the primary reservoir, while arthropods contribute in transmission of the 
bacteria between domestic and wild hosts [53].  Human infection primarily occurs via C. 
burnetii containing aerosol droplets and disease usually manifests as acute Q fever 
although chronic disease may arise.  Acute illnesses are mostly self-limiting while 
chronic infection is marked by endocarditis, hepatitis, osteomyelitis, or infected aortic 
aneurysms [4, 8, 54-56].  This organism is extremely infectious, environmentally stable 
and has been shown to travel as far as 11 miles by wind [57].  Due to such properties, the 
Center for Disease Control and Prevention (CDC), classifies C. burnetii as a category B 
bio-weapon or bio-terror agent [52, 58-59]. 
Coxiella burnetii:  Brief history of discovery 
C. burnetii was independently discovered by Australian and American researchers 
in the late 1930s [60-68].  In 1935, E H Derrick from the Queensland Health department 
led an investigation to identify the etiological agent of a mysterious fever outbreak in 
Brisbane, Australia.  The term “Q fever”, for querulous fever, was coined by him as he 
described the illness of infected abattoir (slaughterhouse) workers in a classic paper 
published in 1937 [64-65, 68].  The clinical symptoms of this illness were initially 
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considered similar to typhus fever, typhoid and paratyphoid fevers but eventually found 
to be different [64-66, 68].  Convalescent sera collected from infected patients were 
titrated against numerous pathogens for antibody detection and none were found positive.  
The absence of such antibodies raised the suspicion of involvement of a new infectious 
organism.  Derrick failed to identify or isolate the etiological agent and efforts to culture 
the organism on bacteriological media proved futile.  However, he was successful in 
infecting guinea pigs with blood and urine obtained from infected patients.  These 
experiments led him to believe that the causative agent of this undiagnosed fever was a 
virus [64-68]. 
Macfarlane Burnet, a virologist working at Walter and Eliza Hall Institute in 
Melbourne, was sought-out by Derrick to identify the Queensland agent.  Burnet, with the 
help of his associate Mavis Freeman, began investigations in 1936 [64-67].  They not 
only infected guinea pigs with tissue material provided by Derrick but also studied the 
infection in mice and monkey models.  Their efforts to grow the pathogen on the 
chorioallantoic membrane of embryonated eggs were partially successful.  Infected 
mouse spleens stained with haematoxylin and eosin gave the first indications of the 
rickettsial nature of this unknown organism [64-67].  Later, serological experiments with 
convalescent sera obtained from typhus and Q-fever patients showed that emulsified 
spleen tissue agglutinated with Q-fever patient sera but not with Typhus sera.  Burnet 
then cautiously concluded that the causative agent of Brisbane‟s fever outbreak was a 
new rickettsial pathogen [64-67]. 
During the same period, at the Rocky Mountain Laboratory (RML), Montana, US 
scientists were studying Rocky Mountain spotted fever (RMSF) [60-62, 68-70].  Gordon 
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Davis, who had joined RML in 1930 as a bacteriologist was investigating the ecology of 
RMSF.  Davis studied rickettsial transmission by feeding ticks onto guinea pigs and 
noting their rectal temperatures over time.  In 1935, Davis received a batch of 
Dermacentor andersoni ticks collected from the Nile Mile Creek area in Western 
Montana.  While conducting his experiments, he observed that one of the guinea pigs 
developed a febrile illness after feeding by ticks from Nine Mile Creek, but the symptoms 
differed from those of RMSF.  Blood obtained from the infected guinea pig would cause 
fever in freshly injected guinea pigs, but no bacterial growth was observed in axenic 
media [62, 68, 70]. 
Meanwhile, Herald Cox, who obtained his doctoral degree from John Hopkins 
University, joined RML in 1936.  He was assigned to work with Davis on the new 
infectious agent.  After a series of studies, Davis and Cox discovered that the new agent 
was rickettsia-like and easily passed through Berkefeld filters [62, 68, 70].  In 1938 Cox 
was successful in cultivating the organism in embryonated eggs [71].  The scientific 
curiosity about this organism continued until a laboratory worker got infected with the  
Nine Mile fever and his blood transmitted febrile illness to guinea pigs [63, 68, 70].  The 
Australian illness was connected to the “Nine Mile” agent when guinea pigs exposed to 
the Australian organism remained protected when challenged with the laboratory workers 
blood.  These experiments linked the Q fever of the US and Australia [64, 72-75].  At 
first, the new agent was named Rickettsia diaporica by Cox and Rickettsia burnetii by 
Burnet, but in 1948 was renamed Coxiella burnetii to honor Cox and Burnet for their 
extraordinary contributions and because the organism was not similar to true rickettsial 
organisms [64, 71-72, 76-77]. 
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Coxiella burnetii:  Epidemiology 
Host Distribution 
C. burnetii infects a diverse range of hosts including humans, ruminants (cattle, 
sheep and goats), pets (cats and dogs), ticks, horses, pigs, camels, buffaloes, birds and 
occasionally reptiles [4, 78-80].  Among animals, domestic ruminants are considered to 
be the primary reservoirs and the largest source of infection for humans [4, 48, 53, 81].  
Unlike humans, infected animals do not show any symptoms of Q fever [4, 48].  
However, C. burnetii infection in animals can manifest clinically as late term abortions 
[4, 48].  Uterus and mammary glands are the most crucial sites of chronic C. burnetii 
infection in ruminants [48].  Infected animals frequently shed Coxiella in their urine, 
feces, milk, and birth products, from which humans are exposed [4, 48].  Maximum 
shedding occurs during parturition but milk also contains large amounts of C. burnetii [4, 
82-85].  Epidemiological data clearly show that dairy cows become chronically infected 
more often than sheep and goats [4, 80, 82, 86-89].  The current prevalence of coxiellosis 
in domestic ruminants is not known as thorough seroepidemiological studies were last 
conducted around 30 years ago [4, 48, 52, 81].  Besides domestic livestock, C. burnetii is 
also chronically carried by pets.  Dogs are thought to be infected by tick bites, by 
placenta consumption or by ingestion of milk containing C. burnetii.  Infection in dogs 
often leads to the death of pups [4, 48].  Epidemiological studies indicate that humans can 
acquire Q fever from infected dogs and cats [4, 48, 90-92]. 
Other crucial hosts of C. burnetii include multiple species of arthropods which 
can act as vectors for disease transmission between animals [4, 48].  Evidence of C. 
burnetii infection has been shown in over 40 tick species, fleas, mites, flies and other 
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arthropods [4, 46].  Ticks are believed to play a crucial role in the maintenance and 
transfer of the pathogen between infected wild and domestic mammals [4, 46, 81].  Tick 
borne transmission of coxiellosis among wild vertebrates like rodents, lagomorphs, and 
wild birds is prevalent [46, 80, 93].  However, the role of ticks in the passage and cycling 
of C. burnetii between various species needs to be defined precisely.  Human Q fever 
transmission via ticks is rare but possible [74].  C. burnetii can also be carried by 
unusually rare hosts like snakes, tortoises [80], and sea lions [94]. 
Geographic Distribution 
Q fever has a worldwide distribution and has been reported from more than 50 
countries in various parts of the world [4, 46].  New evidence shows the presence of 
infection in New Zealand, the only country previously thought to be free of these bacteria 
[48, 95-96].  Serological screenings indicate that C. burnetii infections are more frequent 
in tropical than in temperate climates [48].  Most countries in Europe and Asia have 
diagnosed and reported Q fever cases in humans and animals [4, 97-99].  A major 
outbreak of Q fever was recently reported from the Netherlands [100].  The outbreak, 
beginning in 2007, has infected more than 2300 humans and continues, although control 
measures appear to be lessening the case numbers [52, 100-101].  This epidemic has 
resulted in severe economic losses as more than 50,000 dairy goats have been slaughtered 
to prevent disease spread [100, 102].  Countries like France and Australia, where the 
disease is extensively studied, show higher incidence rates of Q fever than the United 
States [4, 46, 53, 103].  In the United States, cases of Q fever have increased from 21 
cases per year (1978-1999) to 51 cases per year (2000-2004).  This increase in the 
number of Q fever cases is likely linked to the disease becoming reportable in the US in 
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1999 [81, 104].  Cases of Q fever have also been reported in US military personnel 
serving in Iraq and Afghanistan [105].  The majority of these patients were found to have 
been in contact with domestic animals or their products [106]. 
Transmission 
C. burnetii is a highly infectious, stable organism primarily transmitted via 
aerosols [52, 57, 59, 107-108].  It can survive in the dust of contaminated premises for 
several months and has a very low infectious dose [4, 59, 109].  C. burnetii aerosol 
contamination often occurs from parturient fluids of infected animals, which may in turn 
infect humans, new-born animals, and other uninfected animals [4, 48].  Infected animals 
also shed the bacteria in feces, urine, and milk.  When dried, bacteria contained within 
these products may become aerosolized [4, 48, 81, 109].  Different types of fomites have 
been identified to serve as vehicles of C. burnetii dissemination as well.  These include 
wool, shoes, clothing, and straw and barn yard materials contaminated with infected 
animal‟s excreta.  Aerosolized bacteria are not only harbored in the contaminated area, 
but may spread long distances by wind [48, 59, 81].  Wind borne dispersion of C. burnetii 
aerosols plays a major role in infection of humans not in direct contact with infected 
animals [57]. 
  Transmission via ingestion of contaminated products has also been implicated in 
C. burnetii infections.  This has primarily been associated with drinking unpasteurized 
milk and eating contaminated meat [4, 59, 84, 100, 110].  Direct person to person 
transmission is very rare, but may be possible in cases of pneumonia [4].  Sexual 
transmission of Coxiellae is yet to be fully established but has been suggested in both 
humans and mice [111-112].  Bacteria has also been isolated from bull semen [113].  
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Data on the transmission of C. burnetii to humans following a tick bite is lacking [74].  
However, it appears that the infected ticks and other arthropods play a significant role in 
maintaining the pathogen in domestic and wild animals [4, 46, 48, 81, 93].  C. burnetii 
infected ticks commonly pass the bacteria transtadially or transovarially to their 
offspring.  Ticks also transmit C. burnetii horizontally (via bite or in feces) to wild 
vertebrates, wild birds, and domestic animals thereby causing both domestic and wild life 
coxiellosis [48, 81, 93, 98, 103]. 
Coxiella burnetii:  Disease 
C. burnetii causes the zoonotic disease Q fever.  Infection can manifest as acute or 
chronic Q fever [4, 65, 80].  In humans, the primary site of infection is alveolar 
macrophages [3, 107].  The signs and symptoms of Q fever differs widely.  More than 
50% of people exposed to C. burnetii will not display any symptoms, while in chronically 
infected cases, the heart and other major organs are typically affected [4, 53]. 
Acute Q fever 
In a typical acute Q fever case, the incubation period ranges from 1 to 3 weeks 
(depending on inoculation dose).  While many cases are inapparent, symptomatic cases 
present as a non-specific flu like illness [4, 54, 114].  The patient experiences a sudden 
onset of high fever (104-105° F) and headache.  The fever peaks within 2-4 days and 
returns to normal after 5-14 days.  In elderly patients (≥40 years) the fever remains for a 
longer duration.  However, in untreated cases, the fever has been shown to last between 5 
to 57 days.  A quarter of infected patients experience symptoms of a biphasic fever [4, 
54, 114-115].  The first phase has the typical acute Q fever symptoms while the second 
phase is characterized by an intermittent appearance of low grade fever lasting anywhere 
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from 1-19 days.  Other indicators like malaise, myalgia, sweats, nausea, vomiting, 
diarrhea, abdominal pain, confusion, sore throat, non-productive cough, chills, and chest 
pain may also be associated with acute Q fever [4]. 
Thirty to fifty percent of patients experiencing high fever develop atypical 
pneumonia, and some may develop hepatitis [4, 54, 114-115].  It is believed that the entry 
route may also play a role in the disease manifestations.  In Nova Scotia, Canada, where 
Q fever cases often manifest as pnuemonia, infection appears to occur through inhalation 
of contaminated aerosols [116-118].  Patients diagnosed with atypical pneumonia reveal 
multiple rounded opacities in both lungs, an increase in reticular markings, atelectasis, 
and also pleural effusion [4].  Such radiographic results are often confused with viral, 
Mycoplasma or Chlamydia infection.  In addition, splenomegaly is noted in about 5% of 
the patients and inspiratory crackles are also reported [4, 116, 119]. 
In Europe, however, it has been suggested that large numbers of infections occur 
through the ingestion of raw milk, leading to granulomatus hepatitis.  It appears that 
during the incubation period many patients have a transient C. burnetii bacteremia, 
resulting in the hematogenous spread of the bacteria to multiple organs (liver, spleen, 
lungs, bone marrow and female genital tract).  Such bacterial spreading ultimately causes 
serious complications such as meningoencephalitis, myocarditis, or pericarditis [4, 8, 56, 
114, 120]. Q fever hepatitis is usually detected by elevated enzyme levels of aspartate 
aminotransferase [AST], alanine aminotransferase [ALT], and alkaline phosphatase.  This 
increase in enzyme levels is often accompanied by abdominal pain (in right 
hypochondrium), anorexia, nausea, vomiting, and diarrhea [4, 8, 56, 114, 120-124].  In 
the most severe cases, destruction of hepatic tissue, coma and death might occur.  Other 
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acute Q fever indicators include myocarditis, pericarditis, skin rash and 
meningoencephalitis [4].  An interesting biological phenomenon observed in over 90% of 
acute Q fever patients is that the leukocyte count stays normal [4]. 
Chronic Q fever 
It is observed that approximately five percent of C.burnetii infections manifest as 
chronic illness and that the majority of these patients are over 40 years of age.  Chronic Q 
fever may develop a month to many years after an acute infection or exposure.  
Individuals with no previous history of acute illness have been shown to have chronic Q 
fever [4, 54, 125-129].  Chronic Q fever is primarily characterized by endocarditis, with 
60-70% of diagnosed chronic Q fever cases revealing this complication.  If left untreated, 
the illness usually proves fatal.  About 90% of chronic Q fever endocarditis patients are 
thought to have had previous cardiac valve defects.  The bacterium generally affects the 
aortic and mitral valves, although prosthetic valve Q fever endocarditis has also been 
reported [4, 54, 126-129].  Clinical symptoms for chronic Q fever endocarditis include 
cardiac valve dysfunction along with low-grade fever, malaise, weakness, fatigue, weight 
loss, chills, anorexia, and night sweats.  Chest X-rays and electrocardiography show 
cardiomegaly, arrhythmia and ventricular hypertrophy.  Chronic Q fever endocarditis 
patients often have peripheral manifestations like digital clubbing and purpuric rash 
(observed in mucosa and extremities) [4, 54, 56, 125-131].  Patients harboring the 
bacteria for extended periods of time invariably suffer from splenomegaly and 




Other prominent clinical presentations of chronic Q fever include vascular 
infections, osteoarticular infections, chronic hepatitis, chronic pulmonary infections, and 
chronic fatigue syndrome [4].  Though rare, C. burnetii vascular infections can be life-
threatening [4].  Q fever has also been associated with fetal morbidity and mortality.  
Reports show that untreated pregnant women infected with C. burnetii, suffered from 
spontaneous abortion, intrauterine growth retardation, oligoamnios, stillbirth, or 
premature delivery [4, 131-132].  C. burnetii appears to colonize the uterus, placenta, and 
mammary glands of an infected pregnant woman [4, 101, 131, 133]. 
Diagnosis, Treatment and Prophylaxis 
Clinical detection of acute Q fever is complicated by its resemblance to many 
infectious diseases [4, 53, 116, 129, 134-137].  Chronic Q fever on the other hand is 
thought to be an under-diagnosed cause of endocarditis.  Q fever cases are primarily 
diagnosed using serology;  immunofluorescent microscopy is used as the primary 
reference method.  Serological testing require detection of both phase II (acute Q fever) 
and phase I (chronic Q fever) antibodies [138].  Titers of IgM and IgG antibodies directed 
against C. burnetii  NM phase II indicate the presence of an acute infection, while titers 
of IgG and IgA antibodies directed against both virulent (Phase I) and avirulent (Phase II) 
forms of C. burnetii are used to determine the occurrence of chronic infections [4, 52-53, 
116, 129, 134-138].  Other diagnostic tools which have been used for C. burnetii 
detection at one time or another include polymerase chain reaction (PCR), 
immunohistochemistry, complement fixation, microagglutination, ELISA, Western 
blotting, dot blotting, slide agglutination, indirect hemolysis, radioimmunoassay, and 
cross-adsorption [4, 52-53, 116, 129, 134-142]. 
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Although C. burnetii resides in acidified vacuoles within cells, efficient treatment 
of acute infections is possible with antibiotics such as teteracycline, cotrimoxazole, 
ofloxacin, and pefloxacin, using a 14 to 21 day course of treatment [4, 81, 131, 143].  
These antibiotics are thought to act bacteriostatically.  Combination therapy using 
doxycycline and chloroquine or OH-chloroquine is a good alternative to antibiotics alone, 
as chloroquine elevates the pH within the PV, restoring a more bactericidal effect for 
doxycycline [4, 8, 53, 81, 143].  Chronic Q fever on the other hand requires treatment 
from18 to 36 months with doxycycline (200 mg daily) and hydroxychloroquine (started 
at 600 mg daily).  In these cases, treated patients require regular eye examination to 
monitor the development of light sensitivity [4, 8, 53, 81, 143].  Because of possible side 
effects, pregnant women suffering from Q fever are not treated with doxycycline and 
chloroquine; instead, cotrimoxazole is substituted although it appears to act 
bacteriostatically [131]. 
Preventive measures for Q fever infection control include vaccination of both 
animals and humans [4, 48, 81].  In animals, vaccination efforts have shown diverse 
responses; chloroform-methanol residue vaccines are considerably better tolerated by 
animals than C. burnetii whole-cell vaccines [144]. Phase I C. burnetii based vaccines 
have been found to be more protective than phase II bacteria [144].  Vaccination of cattle 
protected them against C. burnetii induced abortion, low fetal weight, and chronic 
infertility, but failed to eradicate C. burnetii in animals naturally infected prior to 
vaccination [4, 48, 144].  A European vaccine containing both phase II C. burnetii and 
Chlamydia psittaci was also reportedly used to protect cattle and goats against fertility 
problems [4, 144-145].  However, humans in contact with vaccinated goats were found 
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have developed C. burnetii infections.  Because of the inconsistent results with animal 
vaccinations, domestic animals are not currently being vaccinated routinely [4, 48, 144]. 
In order to prevent Q fever in humans, three different types of vaccine are 
currently available; a formalin-inactivated Q fever vaccine (Q-Vax), prepared from phase 
I C. burnetii Henzerling strain which is only available in Australia; an Investigational 
New Drug (IND) experimental phase I formalin-inactivated vaccine in the USA; and the 
soluble LPS-protein complex chemovaccine extracted from phase I cells by 
trichloroacetic acid, which has been used in Slovakia [4, 53, 81, 146].  None of these 
vaccines are commercially available in the United States [147].  The Australian Q-vax 
vaccine has been found to be highly immunogenic, but requires a skin test prior to 
administration as it causes adverse effects when administered to previously infected 
individuals [4, 148].  Chloroform-methanol pretreatment of phase I C. burnetii cells 
significantly reduces these effects, but does not impart the same level of protection [4, 
149].  Q fever vaccines are highly recommended for livestock handlers, animal product 
processors, veterinarians, and laboratory personnel working with phase I C. burnetii 
infected animals [4, 59, 81, 150].  Research on immunoreactive Coxiella proteins is 
ongoing in an effort to manufacture a safe and effective Q fever vaccine. 
Coxiella burnetii:  Cultivation 
C. burnetii was first cultivated in embryonated hen‟s eggs in 1938 [60].  Culturing 
the bacteria using this method involves inoculation of 5 to 7 day-old embryonated 
chicken eggs.  Inoculated eggs are incubated at 35°C for 10 to 12 days and then 
harvested.  The yolk sac, specifically the yolk sac membrane, has been found to harbor 
large numbers of bacteria, with lesser numbers found within the tissues of the embryo.  C. 
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burnetii isolation and purification from infected eggs is a difficult and lengthy process 
involving homogenization of infected yolk sacs, differential centrifugation and passage 
through density gradients [3, 52, 151-153].  Until the advent of modern tissue culture 
methods, egg yolk-sac growth was the primary means of culturing C. burnetii outside of 
mammalian hosts. 
Historically, C. burnetii cultivation was performed in guinea pigs.  In modern 
science, this method has limited use but still remains as an excellent procedure for phase I 
C. burnetii isolation from contaminated environmental samples [4, 52, 151, 154].  
Animal models for Q fever include mice, rats, rabbits, guinea pigs and monkeys [4, 155-
156].  Guinea pigs are an excellent model for Q fever as it closely mimics the human 
disease.  When infected intranasally or intraperitoneally, guinea pigs develop 
hyperthermia (≥ 40°C) after 5-12 days of incubation, show signs of pneumonia, excrete 
bacteria in their urine, and may develop lesions in their spleen, testes and liver [154, 
157].  Infected guinea pigs remain latently infected and death during convalescence is 
frequently due to degenerative myocarditis.  Serologically, phase II antibodies appear 15 
days post infection, and both phase II and phase I antibodies are seen within the second 
month of infection [4, 52, 154, 157].  Other than guinea pigs, mice are extensively 
employed as animal models for C. burnetii studies.  When infected intranasally or 
intraperitoneally mice remain asymptomatic and do not acquire  fever.  However, 
development of granulomatous lesions in the spleen, liver, kidneys, and adrenals are 
observed.  An increase in bacterial numbers also occurs in the spleen and liver.  




C. burnetii has been found to infect a range of cultured cells; this includes 
primary cells as well as established cell lines.  Often monocytic and macrophage cells 
such as the human acute monocyte leukemia THP-1 cells, J774 and P388D1 macrophage-
like tumor cell lines, various fibroblast cell lines, green monkey kidney (Vero) cells, 
various epithelial cells as well as primary and cultured tick cells [3-4, 151, 162].  While 
C. burnetii purification from cell cultures is far less laborious than isolations from egg 
culture, it still involves several differential centrifugation and density gradient steps to 
produce pure C. burnetii stocks [3-4, 151]. 
Recently, a monumental step in the cultivation of C. burnetii was accomplished; 
the growth of C. burnetii in host-cell free environment [163].  Omsland et al. developed a 
complex nutrient medium for C. burnetii growth under axenic (host cell free) conditions, 
which will profoundly affect our progress in understanding C. burnetii’s role in virulence 
and disease mechanisms [163].  C. burnetii acidified citrate cysteine medium (ACCM) 
was developed by studying C. burnetii’s metabolic requirements using gene expression 
arrays, genomic reconstruction and metabolic typing.  Using a heavy inoculum and 
incubation at 2.5% oxygen tension, this medium supports a 3 log10 increase over 6 days 
time.  Additionally, this media allows the conversion of SCVs to LCVs, and the 
harvested bacteria are highly infectious for Vero cells [163].  This important 
breakthrough will not only facilitate studies regarding this organism‟s pathogenesis and 
genetics, but will ultimately aid in the development of effective Q fever preventatives. 
Coxiella burnetii:  Microbiology 
Taxonomically C. burnetii is classified under the kingdom: Bacteria, Phylum: 
Proteobacteria, Class: γ-Proteobacteria, Order: Legionellales, and Family: Coxiellaceae 
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[4, 164].  It has a bi-phasic life cycle possessing characters for survival both inside and 
outside of a host cell [9]. 
Morphology, ultrastructure and developmental biology 
C. burnetii is a small Gram-negative pleomorphic coccobacillus with two distinct 
morphological forms, the large cell variant (LCV) and the small cell variant (SCV) [9, 
165].  Both forms differ in size, morphology, peptidoglycan content and resistance to 
physical disruption.  The replicative, metabolically active LCV have an approximate 
dimension of 0.3 by 1.0 µm while the environmentally stable, metabolically inactive 
SCVs measure 0.2 to 0.5 µm in length.  LCVs possess a typical Gram-negative cell wall 
structure yet stain in a Gram-variable fashion [9, 165-166].  Therefore, Gimenez staining 
is often used in observing C. burnetii [165].  The LCVs have a thin cell wall with the 
thickness of the outer and inner membrane being approximately 6.5-8 nm including 
membranes, peptidoglycan, and periplasmic space.  In addition, they contain a 
filamentous and dispersed nucleiod region [3, 9, 166-167].  In contrast, SCVs are 
compact, rod shaped with an electron dense nucleoid core surrounded by cytoplasmic and 
outer membranes.  Its cell wall has (i) been measured between 13 and 21 nm in thickness, 
(ii) no discernable periplasmic space, and (iii) a high protein content within the 
periplasmic space.  These forms can survive for long periods in the environment and are 
resistant to many physical and chemical treatments.  Additionally, tests on C. burnetii 
peptidoglycan content demonstrate that the peptidoglycan protein complex (PG-PC) 
shifts from being ~2% in the LCVs to ~32% in SCVs [3, 165, 168].  These properties 
appear to make SCVs insensitive to UV, desiccation, osmotic shock, sonication (in 
distilled H2O >30 min.) and temperatures which inactivate many other bacteria [3, 9, 
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165].  Experiments show that infectious C. burnetii were still detectable after 24 h 
treatments with 0.5% sodium hypochlorite, 2% Roccal, 5% Lysol, or 5% formalin.  
However, 70% ethanol, 5% chloroform, or 5% Enviro-Chem (diquantinary ammonia 
product) effectively inactivate them [52, 81, 169]. 
Differences between the LCV and SCV forms can not only be differentiated by 
size and membrane structure, but also by proteome expression [3, 9].  For example, the 
major outer membrane protein, P1, is expressed in large quantities in LCVs yet its 
expression is reduced in SCVs.  Elongation factors EF-Tu and EF-Ts, along with the 
stationary-phase sigma factor RpoS, also demonstrate increased expressed in C. burnetii 
LCVs.  Meanwhile, proteins found uniquely in SCVs include the histone like protein Hq1 
(a homolog of eukaryotic H1 histone) and a small basic protein designated ScvA [9, 170-
171].  A recent LCV/SCV proteome study has identified several additional proteins with 
differential protein expression; including 15 in LCVs and 4 in SCVs [170]. 
Defined studies analyzing the C. burnetii growth cycle using a synchronous 
infection model has revealed that these bacteria follow the typical growth pattern 
exhibited by a closed bacterial system.  There are defined lag, exponential replication, 
and stationary phases [172].  The lag phase, which extends up to approximately 2 days 
post infection (PI) primarily involves SCV-to-LCV morphogenesis.  The exponential 
phase spans the next 4 days where LCVs grow and replicate within the PV.  The doubling 
time for C. burnetii during this growth phase has been calculated at ~12.4 h.  Stationary 
phase begins ~6 days PI with the re-emergence of SCVs via conversion of LCVs to SCVs 
through a range of transitional forms [172].  Both LCVs and SCVs are highly infectious 
in tissue culture settings.  Growth cycle kinetics will likely depend on the host cell and 
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culture conditions.  The signals which cause a switch from SCV-to-LCV and LCV-to-
SCV inside the PV are still unknown and needs further research.  Ultimately, both LCVs 
and SCVs play crucial roles in C. burnetii’s life cycle in intracellular and extracellular 
environments.  The conversion of LCVs to SCVs allows C. burnetii to stably survive in 
the extracellular environment while intracellular conversion of SCVs to LCVs allows for 
growth and replication of the organism [3, 9, 52]. 
Genetics 
C. burnetii carries a single circular genome which had been estimated to be 
between 1.6 – 2.1 x 10
6
 base pairs in size using traditional mapping techniques [173-
175].  The first C. burnetii strain to be completely sequenced was the classic Nine Mile 
phase I (RSA493 isolate) which was reported by Seshadri et al. [176].  Analysis of the 
sequence revealed a genome of 1,995,275 base pairs with a 42.6% GC content.  The 
genome is predicted to encode 2,094 ORFs.  Of these, 1,022 show homology to genes 
within sequence databases [176-177].  Sequence analysis revealed that a large portion of 
predicted C. burnetii proteins have a pI greater than 9.0, indicating that many of C. 
burnetii‟s proteins are very basic in nature.  This has lead to the theory that C. burnetii’s 
proteins may act as a proton sink; thereby protecting the organism from the high 
concentration of H
+
 ions present within the PV.  In contrast to other obligate intracellular 
bacteria, the genome contains 32 insertion sequence (IS) elements.  In the NMI strain, 21 of 
these IS elements are copies of the IS1111 element.  Eighty three pseudogenes have also 
been detected [176-177].  Analysis of C. burnetii genes shows association with various 
cellular processes like adhesion and invasion (13 ankyrin repeat-containing proteins), 
intracellular trafficking, detoxification mechanisms (multi-drug efflux pumps), and host-
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cell modulation mechanisms (Type I, II, and IVB secretions systems).  Genome analysis 
also indicates that C. burnetii may possess antibiotic resistance potential, as it contains a 
high proportion of multi-drug efflux pumps (MDEP) per mega-base of genome (~11 
MDEP/Mbase).  It is speculated that the MDEPs are used to remove host defense 
molecules from the bacteria during growth within the PV  Recently, other isolates of C. 
burnetii have also been sequenced – MSU Goat Q177 (length: 2,090,565 nt, GC content: 
42%), Dugway 5J108-111 (length: 2,158,758 nt, GC content: 42%), Henzerling strain 
RSA 331 (Length: 2,016,427 nt, GC content: 42%), and the African clinical isolate RSA 
334 (Length: 2,094,010 nt, GC content: 42%).  These sequences demonstrate that C. 
burnetii strains possess genomes of strikingly similar lengths, GC content, and ORF 
content, although gene rearrangements among these strains may provide valuable insight 
into their differences [177]. 
Most C. burnetii isolates have been shown to maintain one large plasmid.  C. 
burnetii NMI carries a 37.4 kb plasmid, designated QpH1, that encodes 40 predicted 
ORF‟s [176-177].  In addition to QpH1, three other related plasmid types have been 
identified and described from different C. burnetii isolates. They are designated QpDG, 
QpDV, and QpRS.  Plasmid-less C. burnetii strains also exist, yet plasmid-homologous 
sequences are found in the chromosome of these strains.  The four plasmid types contain 
both plasmid-specific sequences as well as regions of shared homology [177-181].  
Recent data shows that QpH1 encodes proteins which can be secreted through the Type 4 
Secretion System (T4SS) of Legionella pneumophila [43].  QpH1 genes cpeC (containing 
an F-box domain), cpeD (possessing kinesin-related and coiled coil regions), and the 
QpH1-specific gene cpeE were all secreted by L. pneumophila in a T4SS fashion.  Three 
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other hypothetical proteins (CpeA, CpeB, and CpeF) are shared among the C. bunetii 
plamid types, and are also predicted to be T4SS effectors [43, 176-177]. 
In order to understand C. burnetii‟s evolution and pathogenic potential cross-
genome comparisons have been conducted.  Whole-genome sequences of the K (Q154) 
and G (Q212) human chronic endocarditis isolates and the naturally attenuated Dugway 
(5J108-111) rodent isolate were compared to the NMI (RSA493) isolate.  These 
comparisons reveal both novel gene content (numerous IS elements, genomic 
rearrangements) and distinct collections of pseudogenes which may contribute to the 
pathogen‟s virulence potential.  Fewer IS elements and pseudogenes suggest that the 
Dugway strains lineage may be at an earlier stage of patho-adaptation than the NMI, K, 
and G lineages [182].  
The genetic manipulation of bacteria has been a hallmark of modern molecular 
pathogenesis studies.  Until recently, viable systems to manipulate C. burnetii did not 
exist.  However, studies on understanding the genetic basis of C. burnetii pathogenesis 
are now within reach.  The introduction of Himar1-mediated transposition in C. burnetii 
by Beare et al., demonstrated the successful cloning and characterization of a C. burnetii 
ftsZ mutant generated by mariner-based Himar1 transposon (Tn) mutagenesis [183].  
This first report of successful genetic transformation and clonal isolation in C. burnetii 
involved coelectroporation of C. burnetii with a plasmid encoding for Himar1 C9 
transposase variant and a plasmid containing Himar1 transposon encoding 
chloramphenicol, acetyltransferase, mCherry fluorescent protein, and a ColE1 origin of 
replication.  Mariner family transposon Himar1 randomly mutagenizes C. burnetii‟s 
genome [183].  Combined with the ability to now grow C. burnetii in ACCM [184], these 
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developments make possible many molecular techniques previously absent from C. 
burnetii research. 
Phase Variation and Lipopolysaccharide  
C. burnetii isolated from nature and laboratory animals is virulent and is noted for 
causing disease in humans and animals [3, 151].  Virulent C. burnetii is usually referred 
to be in “phase I”.  The bacteria displays a striking phenomenon of phase variation.  
When phase I organisms are grown for extended periods of time in embryonated eggs or 
tissue culture, bacteria within the culture may convert into the “phase II”, or avirulent 
form of the organism [3, 151].  In its phase I virulence state the organism produces a full 
length lipopolysaccharide (LPS) while phase II organisms possess a severely truncated 
LPS which has lost the O antigen.  If these Phase II C. burnetii are when injected into 
guinea pigs, mice, and hamsters without clonal isolation of the phase II strain, the 
animals become ill and phase I C. burnetii can be isolated from these animals, indicating 
that not all bacteria within the culture had converted to the avirulent form [3, 151].  
Animal studies using clonal isolates of phase II bacteria does not produce disease [185]. 
Phase II C. burnetii’s attenuated virulence is due to a chromosomal deletion that 
eliminates genes associated with O-antigen sugar biosynthesis, including the rare sugar 
virenose (6-deoxy-3-C-methlygulose) [3, 186-189].  Three different LPS chemotypes 
have been reported [40, 187].  Phase I contains full length LPS while Phase II LPS is 
made up of Lipid A and some core sugars, but lacks O-antigen sugars [3, 186-187].  
Another cloned LPS variant (designated Nine Mile Crazy (NMC)) promotes intermediate 
virulence, and produces an LPS of intermediate length [3, 185].  Interestingly, the phase 
II truncation of LPS has been linked to the C. burnetii NM phase II (NMII) strains ability 
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to infect cultured host cells at a rate ~10-fold greater than that observed in NMI.  Even 
though they infect in vitro cells at different rates, both NMI and NMII replicate with the 
same kinetics once inside the host cell in phenotypically indistinguishable PV [3, 38, 185, 
190-191].  In fact, C. burnetii phase variants have been shown to grow at similar rates in 
primary macrophages from guinea pigs, non-human primates and humans.  However, it 
has been suggested that phase II organisms do not grow as well as phase I organisms in 
primary mouse macrophages [3, 23, 38, 40, 190, 192].  Microscopically the forms of C. 
burnetii are indistinguishable from one another, but the serological responses against the 
forms is significantly different.  Antibody titers against phase II C. burnetii antigens is 
much higher in an acute infection while phase I antigen titers are higher in the sera from 
chronic infections [4, 23, 155, 190, 193-195]. 
The LPS chemotype appears to dictate the organism‟s ability to promote disease 
[40, 186-187].  Unlike phase I, phase II C. burnetii is more susceptible to complement 
membrane attack complex [192].  Moreover, the full length LPS of phase I bacteria 
inhibits the binding of antibodies to Coxiella surface proteins.  Phase I LPS not only 
protects C. burnetii from being detected by host innate immune receptors such as Toll 
like receptors (TLRs) in dendritic cells, but also prevents interaction with the CR3 
receptor of macrophages [23, 38, 40].  As the lipid A moieties of both phase I and phase 
II Coxiella are chemically identical, it might not act as a ligand for TLR4 as suggested by 
some studies [40, 187]. 
Coxiella burnetii: Intracellular life style 
Once acquired by inhalation, C. burnetii initially contacts alveolar macrophages 
for invasion and subsequently causes systemic infection [3, 196].  To cause disease, 
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intracellular bacteria must establish themselves within a host cell, replicate, and exit to 
invade other uninfected cells [22, 197].  Like other parasites, C. burnetii employs 
multiple uncharacterized attack strategies for establishment, growth, replication, and 
exiting the a host cell. 
Coxiella adherence and internalization via cytoskeleton re-organization 
Internalization of C. burnetii into host cells is a microfilament-dependent 
endocytotic process [3, 10, 198-199].  Studies on THP-1 cells reveal that upon cell 
attachment, phase I C. burnetii cause a dramatic reorganization of the actin cytoskeleton.  
Restructuring of the actin cytoskeleton induces pronounced membrane protrusions at the 
site of bacterial attachment.  F-actin is seen to accumulate in these membrane protrusions, 
and this accumulation is dependant on host cell tyrosine kinases [200].  When F-actin 
redistribution is blocked by cytochalasin D, such morphological changes do not occur. 
Adherence of phase II C. burnetii does not generate such cellular modifications [10, 199]. 
Membrane protrusions such as membrane ruffling have been associated with 
efficient pathogen uptake, but in the case of C. burnetii phase I, uptake is less efficient 
than phase II uptake.  Differential uptake indicates that different host cell receptors may 
be involved depending on C. burnetii phase type [3, 10-11].  In THP-1 cells, uptake of 
phase II C. burnetii involves the participation of both leukocyte response integrin αvβ3 
receptor and the CR3 receptor, while phase I C. burnetii uptake depends only on αvβ3 
integrin [11].  It is speculated that phase I bacteria restrict the participation of the CR3 
co-receptor upon adherence, thereby dampening the efficiency of internalization.  It is 
possible that the full length LPS of phase I C. burnetii prevent the CR3 receptor‟s 
interaction with the microbe‟s ligand by sterically masking bacterial surface proteins [10-
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11, 201].  Differential uptake of phase variants is also observed in Vero epithelial cells 
and L-929 fibroblasts (non phagocytic) which do not contain αvβ3 integrin and CR3 
receptors [3].  As phase II C. burnetii contain a truncated LPS with a much lower 
carbohydrate content when compared to phase I organisms, they are extremely 
hydrophobic.  It is speculated that this increase in phase II surface hydrophobicity 
encourages non-specific hydrophobic interactions between host plasma membrane and 
cognate receptors, thereby allowing greater eukaryotic interaction and cellular uptake.  
The C. burnetii ligands mediating such uptake are thought to be proteinaceous since 
pretreatment of the bacteria with proteases dramatically inhibits internalization [3]. 
Type IV Secretion System 
Protein export systems or secretion systems in gram negative bacteria specifically 
mediate either insertion of proteins into or translocation of proteins across their cell 
membranes [202-203].  Secretion of virulence determinants is a crucial process for 
bacterial functioning and operation.  One secretion system which allows a number of 
pathogenic bacteria to deliver proteins with effector functions into the host cytosol is the 
Type 4 Secretion System (T4SS) [202-203].  Sequence data indicates that C. burnetii 
possesses a type IVB secretion system (T4BSS) that has homology to the Dot/Icm 
T4BSS of L. pneumophila [18, 204-205].  Composed of 26 proteins, the Dot/Icm of L. 
pneumophila is a type IVB (T4BSS ) effector protein delivery apparatus.  C. burnetii „s 
genome contains 23 of the 26 Dot/Icm genes but lacks homologs to the chaperone protein 
icmR and inner membrane proteins DotJ and DotV [18, 204-205].  C. burnetii T4BSS 
genes are located primarily within two loci, designated regions I (RI) and II (RII) [206-
207].  Morgan et al. recently demonstrated the  polar localization of T4BSS within C. 
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burnetii during infection of host cells [207]. Studies also reveal that C. burnetii T4BSS 
RI genes are expressed early in infection  [206].  RI genes were observed to be 
transcriptionally linked.  In addition, it was also observed that de novo transcription of 
icmX, icmV, and icmT begins by 8 hours post infection (hpi).  Further analysis of 
transcript levels for RI genes - icmX, icmW, icmV, dotA, dotB, and icmT within the first 
24 hpi showed an initial increase followed by a late decrease.  Protein levels of IcmT 
increased significantly from 8hpi to 24 hpi. However, IcmT protein levels remained 
relatively constant from after this marked initial rise [206].  Other gene expression studies 
using Vero cells infected with avirulent C. burnetii NMII  and reverse transcriptase-PCR 
also indicates that T4BSS genes - icmS, icmW, icmQ, and dotB were transcribed within 
24 hpi [3, 18, 44, 204-205, 208]. 
Studies have also demonstrated functional similarity of C. burnetii T4BSS 
components with L. pneumophila Icm/Dot pathogenesis system [208-209].  
Complementation studies using L. pneumophila Dot/Icm dependent secretion has shown 
that L. pneumophila mutants of dotB, icmS, icmW and icmT can be complemented by the 
C. burnetii homologs while icmX, icmQ, dotM, dotL, dotN and dotO cannot [205, 208-
209].  Interestingly, these studies show that four of five C. burnetii T4BSS RI genes were 
able to complement the L.  pneumophila T4BSS mutants, whereas none of the five RII 
homologs could compliment, suggesting a functional distinction exists between the L.  
pneumophila and C. burnetii T4BSSs [3, 18, 44, 204, 208-210].  An analysis on C. 
burnetii icmQ complementation failure indicates that lack of binding with L. 
pneumophila IcmR may be responsible for this unsuccessful activity.  However, research 
demonstrates that both C. burnetii and L. pneumophila express non-homologous proteins 
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which are functionally similar, to IcmR [204, 211].  Other protein function studies on C. 
burnetii T4SS chaperones IcmS and IcmW have clearly indicated conservation of 
Dot/Icm T4BSS substrate recognition [204-205, 208].  Although more than 70 L. 
pneumophila Dot/Icm effector proteins have been recognized, C. burnetii does not 
express homologs of these proteins.  This is likely due to the differences between the 
intracellular environments of these bacteria [18, 212]. 
As genetic manipulation of C. burnetii is still in its infancy, indirect approaches 
have been used to detect and identify T4BSS effector proteins.  Bio-informatic screens 
have been performed on the pathogens proteome as a means to identify eukaryotic-like 
motifs/domains that functionally mimic or inhibit the activity of host cell proteins [3, 18, 
44-45, 210].  The C. burnetii genome encodes multiple proteins with eukaryotic-like 
features.  This includes proteins with ankyrin repeat domains (Anks), tetratricopeptide 
repeats (TPR), coiled coil domains (CCD), leucine-rich repeats (LRR), GTPase domains, 
ubiquitination-related motifs, and multiple kinases and phosphatases [18, 44-45, 182, 
210].  The predicted function of these identified proteins is divided into two categories; 
(i) proteins containing Ank, TPR, CCD, and LRR domains represent ORFs which might 
be involved in direct protein-protein interactions with host proteins while (ii)  proteins 
containing F-box, GTPase, kinase, and phosphatase homology may participate in host 
cell signal transduction pathway regulation [18, 44-45, 182, 210]. 
Multiple screening techniques have been employed in an attempt to identify C. 
burnetii T4BSS substrates.  A number have been identified using L. pneumophila as a 
surrogate host in conjunction with a protein fusion-adenylate cyclase (CyaA) enzymatic 
reporter assay[18, 43-44].  The Identified Dot/Icm T4BSS substrates include four C. 
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burnetii Anks (AnkA, AnkB, AnkF, and AnkG) and several C. burnetii plasmid borne 
proteins (CpeC, CpeD, CpeA, CpeB, and CpeF).  Other Ank repeat containing proteins 
from different Coxiella isolates have also been shown to be secreted in a Dot/Icm-
dependent fashion [18, 44].  Recent data indicates that the signal for Dot/Icm-mediated 
translocation resides in the C-terminus of these proteins and that a few of the Anks 
involve chaperone IcmS for secretion [18, 43-44, 182].  Other in silico screens for T4BSS 
genes identified two candidate effectors with eukaryotic-like features; CBU1206, which 
encodes a sterol reductase, and CBU1213, which encodes an ankyrin repeat domain-
containing protein (AnkI).  These substrates are located in the putative C. burnetii 
pathogenicity island [176, 182].  Identifying other C. burnetii T4BSS substrates continues 
in multiple labs.  C. burnetii Dot/Icm substrates fused to fluorescent proteins and 
ectopically expressed in mammalian cells suggests that AnkO (CBUD1108) and AnkJ 
(CBUD1338) traffic to the PV membrane and mitochondria, respectively [18].  A recent 
study identified 32 new Dot/Icm dependent C. burnetii effectors using a fluorescence-
based β-lactamase (TEM1) translocation assay and calmodulin-dependent adenylate 
cyclase (CyaA) assay and L.  pneumophila as a surrogate host  These putative substrates 
were selected on the basis of their interaction with DotF, a T4BSS component believed to 
act as a chaperone/substrate binding protein, and bioinformatic approaches [45]. 
Coxiella phagosome maturation 
After inhalation and subsequent infection of alveolar macrophages, C. burnetii 
replicates within a PV that retains many of the features of a mature phagolysosome [3, 
190].  At the cellular level, studies suggest that there is a delay in phagolysosomal 
maturation of C. burnetii containing vesicles and that as C. burnetii replicates, host 
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vesicles are specifically trafficked to the PV to produce a spacious PV (SPV) [3, 213].  
Following phagocytosis, the nascent Coxiella-containing phagosome proceeds through 
the endocytic pathway to eventually fuse with the lysosomal compartment.  During this 
trafficking, the C. burnetii containing phagosome (< 6 hpi) is observed to recruit the 
small GTPases Rab5 and Rab7 (in low amounts), which are prototypic markers of early 
and late endosomes involved in the regulation of membrane trafficking [14, 17, 214].  
Rab5 recruitment occurs by 5 minutes pi, peaks at 20 minutes pi and goes down by 60 
minutes pi.  On the other hand, Rab7 recruitment gradually increases over the infection 
course and is observed 48-72 hpi.  Recent studies show that dominant negative mutants 
of Rab5 have decreased C. burnetii cell entry entry while dominant negative mutants of 
both Rab5 and Rab7 do not allow C. burnetii PV formation [14, 17, 214].  PV formation 
is also dependent upon F-actin recruitment.  Rho GTPases are known to regulate actin 
dynamics and in Hela cells C. burnetii vacuole formation appears to be reliant on two 
such proteins, RhoA and Cdc42 [215]. 
The membranes of early C. burnetii PVs (5 min pi) have been shown to contain 
autophagosome markers, microtubule-associated protein light-chain 3 (LC3), and Rab24 
[3, 14, 16-17, 214].  The ultimate association of the C. burnetii PV with lysosomes is 
demonstrated by the presence of lysosomal enzymes, acid phosphatase, and cathepsin D 
[3].  When compared to latex beads, which acquire lysosomal enzymes in approximately 
15 min, C. burnetii PVs take approximately 2 hours to accumulate these enzymes [3, 
213].  C. burnetii’s interaction with the autophagy pathway is thought to allow an 
increase in the size of the PV and aid in the initiation of C. burnetii SCV to LCV 
differentiation via delivery of nutrients [3, 214].  Recent data shows that Rab1b is 
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recruited to the C. burnetii PV after 6 hpi.  Rab1 is typically involved in secretory 
pathway transport between the endoplasmic reticulum and the Golgi apparatus and 
disruption of the secretory pathway has been shown to affect the spaciousness of C. 
burnetii PV [216]. 
Features of the mature Coxiella PV and infected host cells 
The first information suggesting that C. burnetii grows and replicates inside the 
phagolysosome of a host cell was based on the cytochemical localization of the 
lysosomal enzymes acid phosphatase and 5′-nucleotidase [3, 18, 190, 217].  Subsequent 
experiments demonstrated that the C. burnetii PV also acquires thorium dioxide from 
secondary lysosomes and becomes acidified [213].  When C. burnetii enters into the 
exponential phase at ~2 days pi, the maturing PV often swells to occupy the majority of 
host cell cytoplasm and interacts extensively with both endolysomal vesicles and 
autophagosomes [3, 13, 18].  This mature PVs membrane contains vacuolar H+ ATPase, 
Rab7, lysosome-associated membrane proteins-1, -2, and -3, flotillin 1 and 2, LC3, and 
Rab24 [2, 12, 16-18, 218].  The lumen of the PV is moderately acidic (~pH 5) as well [3, 
18].  Other prominent proteins recruited to the PV membrane include the autophagy 
pathway protein Beclin 1 and the anti-apoptotic protein Bcl 2 [219]. 
The detection of lipid raft proteins flotillin 1 and 2 on the PV membrane clearly 
indicates a cholesterol rich PV [218, 220].  Investigations on the role of host cholesterol 
in biogenesis and maintenance of the C. burnetii PV show that infected Vero cells 
produce 73% more cholesterol than uninfected cells [3, 218].  An increased transcription 
of host genes involved in both cholesterol uptake (e.g.  LDL receptor) and biosynthesis 
(e.g.  lanosterol synthase) was also observed in C. burnetii infected Vero cells.  
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U18666A, lovastatin, or 25-hydroxycholesterol (cholesterol uptake and/or biosynthesis 
inhibitors) treatment on infected cells resulted in the alteration of the C. burnetii PV and 
stalling of replication [218, 220].  Together these data suggest that free access to host 
cholesterol is required for C. burnetii growth and replication.  Recent studies have 
suggested that while the bacterium lacks enzymes for de novo cholesterol biosynthesis, it 
might use CBU1206 (a eukaryote-like Δ24 sterol reductase homolog) to modify host cell 
sterols during its intracellular growth [221]. 
Host cells often sacrifice themselves to defend against infections from 
intracellular pathogens.  The function of the host cell apoptotic pathway has been shown 
to be altered during C. burnetii infection [19-20].  C. burnetii was shown to actively 
inhibit apoptosis in macrophages exposed to inducers of both extrinsic (treated with 
TNFα) and intrinsic (treatment with staurosporine) apoptotic pathways in a bacterial 
protein synthesis dependant manner [19].  Other data indicates that C. burnetii mediated 
the synthesis of host anti-apoptotic proteins A1/Bfl-1 and c-IAP2, which could then 
directly, or indirectly, prevent the release of cytochrome c from mitochondria, thereby 
interfering with the intrinsic cell death pathway during infection [20].  In addition, C. 
burnetii was shown to activate the pro-survival host kinases Akt and Erk1/2 during 
infection, protecting infected host cells from apoptosis [21].  These observations indicate 






Once inhaled by the human host, C. burnetii typically infects alveolar 
macrophages [4].  The fact that C. burnetii can survive and grow inside a professional 
phagocyte reveals the bacterium‟s capability to overcome host innate immune responses.  
Cytokine overproduction, a commonly reported feature of primary C. burnetii infection, 
has led to investigations of the role Toll Like Receptors (TLR) and the innate immune 
response play in controlling C. burnetii infections.  These investigations show that 
C.burnetii NMI LPS functions as TLR4 antagonists [37]. Studies also show that TLR4 
deficient mice clear C.burnetii infection successfully, making the role of TLR4 unclear 
[36].  Contrasting studies have revealed that instead of TLR4, TLR2 plays a major role in 
macrophage activation during C. burnetii NMII infection [36].  Research on TLR2 (not 
TLR4) deficient murine macrophages show an increased susceptibility to C. burnetii 
infection with a decreased production of tumor necrosis factor-α (TNF-α) and 
interleukin-12 (IL12).  The same study indicated that activation of TLR2 may limit 
intracellular replication as bacterial numbers in macrophages from TLR2 deficient mice 
were higher than in wild type or TLR4 deficient macrophages [36]. 
Interestingly, the LPS of virulent C. burnetii Nine Mile Phase I (NMI) organisms, 
but not C. burnetii NMII, interferes with activation of dendritic cells by masking the 
TLR-4 ligand [38].  However, purified C. burnetii NMI Lipid A itself fails to stimulate 
both TLR2 and TLR4 [36].  Dendritic cells (DC), characterized by their high endocytic 
activity, function as antigen presenting cells as they scavenge the surrounding 
environment for pathogens.  C. burnetii NMI is able to infect and grow within human 
DCs without initiating an inflammatory burst, whereas C. burnetii NMII cause dramatic 
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DC maturation resulting in surface expression of the CD80, CD83, CD86, CD40, and 
HLA-DR (maturation markers) and increased IL-12 and TNF secretion [38, 40]. 
Although the control and clearance of C. burnetii infection is T-cell dependent 
[23], specific data on T-cell activation signals are lacking.  The release of cytokines from 
macrophages is centrally important to many aspects of T cell function and  activation 
[222].  Studies on cytokine expression at a cellular level indicate that an in vitro 
stimulation of peripheral blood mononuclear cells (PBMC) by virulent and avirulent C. 
burnetii causes the production of pro-inflammatory cytokines - RANTES and MCP-1 
[223].  Both RANTES and MCP-1 are chemotactic cytokines and play an active role in 
recruiting T cells and leukocytes into inflammatory sites.  However, no data exists on 
recruitment of T cells or macrophages.  A DNA microarray study of host cell 
transcriptional responses to C. burnetii infection also indicates up-regulation of certain 
chemokines (RANTES, SCYA3, SCYA4, and IL-8) [42].  It appears that the effects of 
host cell pro-inflammatory cytokine response are being annulled by C. burnetii by 
unidentified mechanisms. 
Other cytokine production studies with C. burnetii infected cells do not provide a 
clear picture on how C. burnetii is able to prevent activation of professional phagocytes 
and T cells.  Recent data on the programmed activation of monocyte-derived 
macrophages (MDM) infected with C. burnetii suggests that it stimulates an atypical M2 
form of activation [39, 224].  Classically, the M1 form of activation is induced with a 
microbial stimuli (e.g., LPS), cytokines (e.g., TNF and GM-CSF), or by IFNγ alone [39, 






 phenotype.  They 
also produce reactive oxygen, nitrogen intermediates, and inflammatory cytokines (IL-1β, 
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phenotype with a variable capacity to produce inflammatory cytokines [39, 224].  IL-10 
is an anti-inflammatory cytokine, and its role  has been extensively studied in chronic Q-
fever patients where it has been implicated in the enhanced persistence of C. burnetii in 
infected hosts, possibly due to its anti-inflammatory properties [225].  It is still unclear if 
this phenomenon is controlled by C. burnetii protein synthesis.  Many of the innate 
immune responses seen during in vitro and in vivo C. burnetii studies have been 
attributed to LPS and intrinsic properties of the bacteria.  These approaches have not 
addressed the possibility that C. burnetii actively modulates the innate immune response 
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Background.  Coxiella burnetii is an intracellular bacterial pathogen that causes acute 
and chronic disease in humans.  Bacterial replication occurs within enlarged 
parasitophorous vacuoles (PV) of eukaryotic cells, the biogenesis and maintenance of 
which is dependent on C. burnetii protein synthesis.  These observations suggest that C. 
burnetii actively subverts host cell processes, however little is known about the cellular 
biology mechanisms manipulated by the pathogen during infection.  Here, we examined 
host cell gene expression changes specifically induced by C. burnetii proteins during 
infection. 
Results.  We have identified 36 host cell genes that are specifically regulated when de 
novo C. burnetii protein synthesis occurs during infection using comparative microarray 
analysis.  Two parallel sets of infected and uninfected THP-1 cells were grown for 48 h 
followed by the addition of chloramphenicol (CAM) to 10µg/ml in one set.  Total RNA 
was harvested at 72 hpi from all conditions, and microarrays performed using Phalanx 
Human OneArray™ slides.  A total of 784 (mock treated) and 901 (CAM treated) THP-1 
genes were up or down regulated ≥ 2 fold in the C. burnetii infected vs. uninfected cell 
sets, respectively.  Comparisons between the complementary data sets (using >0 fold), 
eliminated the common gene expression changes.  A stringent comparison (≥2 fold) 
between the separate microarrays revealed 36 host cell genes modulated by C. burnetii 
protein synthesis.  Ontological analysis of these genes identified the innate immune 
response, cell death and proliferation, vesicle trafficking and development, lipid 
homeostasis, and cytoskeletal organization as predominant cellular functions modulated 
by C. burnetii protein synthesis. 
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Conclusions.  Collectively, these data indicate that C. burnetii proteins actively regulate 
the expression of specific host cell genes and pathways.  This is in addition to host cell 
genes that respond to the presence of the pathogen whether or not it is actively 
synthesizing proteins.  These findings indicate that C. burnetii modulates the host cell 
gene expression to avoid the immune response, preserve the host cell from death, and 
direct the development and maintenance of a replicative PV by controlling vesicle 





Coxiella burnetii is a Gram-negative, pleomorphic, intracellular bacterial 
pathogen with a worldwide distribution [3-4]. Virulent strains cause human Q-fever, 
which is usually marked by an acute self-limiting flu-like illness. Persistent infections 
usually progress into chronic disease [4, 23, 81]. Human infection occurs via inhalation 
of aerosols contaminated with C. burneti. The small cell variant (SCV) form of the 
bacterium, which are metabolically inactive and environmentally stable, are believed to 
be responsible for most environmentally acquired infections.  SCVs passively ingested by 
mononuclear phagocytes are trafficked along the endocytic pathway and associate with a 
variety of endocytic and autophagic markers before ultimately residing within a 
parasitophorous vacoule (PV) with characteristics of a secondary lysosome [3-4, 81]. 
Here, they undergo a replicative lag phase of 1-2 days while differentiating into the 
metabolically active large cell variants (LCVs).  Although they are not environmentally 
stable, LCVs are infectious in laboratory settings and pose a risk of causing disease.  
After differentiation, LCVs then undergo exponential replication for ~4 days (log phase) 
before beginning an asynchronous conversion back to SCVs at ~6 days post infection 
(PI) [9, 172]. LCV replication is accompanied by a remarkable expansion of the PV, 
which eventually occupies the majority of the host cell [3, 12]. 
Intracellular bacterial pathogens are known to operate by targeting and subverting 
vital intracellular pathways of the host [22, 226].  Bacterial proteins are a key factor in 
this subversion of host cell molecular mechanisms [3, 18, 22, 210].  Biogenesis and 
maintenance of the PV, interaction with the autophagic pathway, and inhibition of host 
cell apoptosis are all dependent on C. burnetii protein synthesis [3, 19-20, 218, 227].  
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After ingestion by a host cell, C. burnetii PV maturation experiences a delay when 
compared to vacuoles carrying latex beads or dead C. burnetii [12, 213].  This delay in 
phagolysosomal maturation requires ongoing bacterial protein synthesis [12].  C. burnetii 
protein synthesis is also required for the fusogenicity of C. burnetii containing vacuoles, 
PV fusion with host vesicles, and in the maintenance of a spacious PV (SPV) during 
logarithmic bacterial growth [12, 213].  Transient interruption of bacterial protein 
synthesis results in cessation of SPV-specific vesicle trafficking and SPV collapse [12, 
213].  The C. burnetii PV is thought to interact with the autophagic pathway as a means 
to provide metabolites to the bacterium.  This interaction is also a pathogen driven 
activity [14].  Additionally, an examination of the PV has revealed increased amounts of 
cholesterol in the membranes[218].  Interestingly, C. burnetii infected cells have been 
observed to dramatically increase cholesterol production.  During log growth, the PV 
expands and is accompanied by increased transcription of host genes involved in both 
cholesterol uptake (e.g. LDL receptor) and biosynthesis (e.g. lanosterol synthase) [3, 
218]. 
Recently, the function of the host cell apoptotic pathway has been shown to be 
altered during C. burnetii infection. C. burnetii was shown to actively inhibit apoptosis in 
macrophages exposed to inducers of both the extrinsic and intrinsic apoptotic pathways in 
a bacterial protein synthesis dependant manner [19].  This antiapoptotic activity causes a 
marked reduction in activated caspase-3, caspase-9, and poly-ADP (ribose) polymerase 
(PARP) processing. Other data indicate that C. burnetii mediates the synthesis of host 
anti-apoptotic proteins A1/Bfl-1 and c-IAP2, which might directly or indirectly prevent 
release of cytochrome C from mitochondria, interfering with the intrinsic cell death 
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pathway during infection [20].  Moreover, activation of the pro-survival host kinases Akt 
and Erk1/2 by C. burnetii was shown to protect infected host cells from apoptosis [21].  
Despite the information on processes that appear to be affected by C. burnetii proteins, 
little is known about the host molecular mechanisms being targeted throughout the course 
of infection. 
A common theme among bacterial pathogens, including C. burnetii, is the ability 
to secrete effector proteins into the host cell as part of their pathogenic strategy [18, 22]. 
The possession of a type IV secretion system (T4SS) by C. burnetii suggests that effector 
proteins might be delivered to the host cell via this machinery [3, 18, 44, 207]. As the 
genetic manipulation of C. burnetii is in its infancy, indirect approaches such as 
bioinformatic screens have been useful in predicting putative T4SS substrates. Recent 
data indicate that C. burnetii encodes multiple proteins with eukaryotic-like domains, 
including ankyrin repeat binding domains (Anks), tetratricopeptide repeats (TPRs), 
coiled-coil domains (CCDs), leucine-rich repeats (LRRs), GTPase domains, 
ubiquitination-related motifs, and multiple kinases and phosphatases [3, 176, 182]. 
Studies have shown that a number of the C. burnetii encoded Ank proteins are secreted 
into the host cell cytoplasm through the Legionella pneumophila T4SS [44, 182, 228]. 
Three of these proteins associate with the PV membrane, microtubules, and 
mitochondria, respectively, when expressed ectopically within eukaryotic cells [44]. 
These observations suggest that C. burnetii proteins directly interact and exploit 
mammalian intracellular pathways leading to the establishment and prolongation of the 
replicative niche.  Here, we use the avirulent C. burnetii Nine Mile phase II (NMII) strain 
and the transient inhibition of bacterial protein synthesis as a means to elucidate host 
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molecular mechanisms that are being actively targeted by C. burnetii during infection.   
While the C. burnetii NMII strain does not cause Q fever, it is a recognized model for the 
analysis of molecular host cell-pathogen interactions.  Recent studies clearly demonstrate 
that the virulent Nine Mile phase I (NMI) and avirulent NMII strains grow at similar rates 
and are trafficked to similar intracellular vacuoles during infection of cultured monocytic 
cells (THP-1) as well as primary monocytes/macrophages [229-230], making NMII an 
excellent model for molecular studies of this unusual pathogen. In the current study, we 
have analyzed C. burnetii NMII protein induced gene expression changes in infected 
THP-1 cells.  Using microarray technology we have examined the global transcriptional 
response of THP-1 cells during C. burnetii infection by transiently inhibiting 
(bacteriostatically) bacterial protein synthesis during the logarithmic phase of infection 
and comparing this to normal (mock treated) infections ran in parallel.  Using stringent 
comparative microarray data analyses, we have discovered 36 previously unidentified 
host genes whose expression is significantly changed by C. burnetii proteins.  Gene 
ontology analysis on these data was performed to define the host cell processes being 
targeted by this bacterium during infection. 
Methods 
C. burnetii and cell culture growth and infection.  C. burnetii Nine Mile phase 
II was grown in Vero cells (CCL-81; ATCC, Manassas, VA) and purified as previously 
described [207].  Non-adherent THP-1 human monocytic leukemia cells (TIB-202; 
ATCC) were propagated in RPMI 1640 medium (Gibco, Carlsbad, CA) supplemented 
with 1mM sodium pyruvate, and 10% fetal bovine serum (FBS) at 37°C in 5% CO2. 
THP-1 cells between passages 6-10 were used in all experiments [19].  Briefly, purified 
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C. burnetii NMII SCVs at a genome equivalent MOI of 15 were used to establish a 
synchronous infection.  To ensure close host cell-bacteria contact, C. burnetii SCVs 
diluted in RPMI 1640 containing 10% FBS were incubated in 25cm
2
 tissue culture flasks 
(Becton Dickinson, Franklin Lakes, NJ) with 5x10
6
 THP-1 cells in a total volume of 2.5 
ml.  Incubations were performed at 37°C in an atmosphere of 5% CO2 for 4 hours.  Cells 
were pelleted by centrifugation at 600g for 5 minutes, washed with fresh media and 
pelleted again.  Cell pellets were then re-suspended in 5ml of fresh media (final 
concentration = 10
6
 cells/ml) and transferred to new 25cm
2
 tissue culture flasks (this 
represents T=0).  Cells were pelleted again at 48 hours post infection (hpi) and re-
suspended in fresh media with or without the bacterial protein synthesis inhibitor 
chloramphenicol (CAM, a final concentration of 10µg/ml), as needed.  Cells were then 
incubated for an additional 24 hours for either total RNA harvest or microscopy analysis 
(see Figure 3.1).  Infected and uninfected cells were handled identically and a total of 
three experiments (N=3) were carried out for microarray analysis. 
Comparative microarray design and analysis.  In order to perform the 
microarray hybridizations, two parallel infection and treatment protocols were employed.  
A schematic of the comparative microarray experimental design highlighting the separate 
treatment conditions is shown in Figure 3.1.  Using this experimental design, a 
comparison was made between the THP-1 transcriptional responses of (i) uninfected 
versus C. burnetii NMII infected and (ii) uninfected versus C. burnetii NMII infected 
THP-1 cells transiently treated with bacteriostatic levels (10µg/ml) of CAM.  Briefly, 
infections were initiated and cultured in parallel with uninfected cells.  At 48 hpi media 
containing CAM (10µg/ml) was added to one set of cells (uninfected and infected THP-1 
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cells) and culturing was continued.  The other set of cells were mock treated with normal 
media.  Total RNA was isolated at 72 hpi from all conditions.  Microarrays were 
performed for both conditions and the results were compared to define the host genes 
modulated by de novo synthesized C. burnetii NMII proteins.  The 48-72 hpi time frame 
was used because (i) C. burnetii would be in logarithmic growth [172] and, (ii) previous 
studies have shown observable changes in PV size within C. burnetii infected Vero cells 
when treated overnight with 10µg/ml of CAM at 48 hpi[12]. 
RNA extraction, microarray hybridization and data analysis.  Following the 
infection and treatment protocols (Figure 3.1), total RNA was isolated using Tri-Reagent 
(Ambion, Austin, TX) according to the manufacture‟s recommendations.  All RNA 
samples were DNase treated using RQ1 DNase (Promega, Madison, WI) and confirmed 
DNA free by PCR.  RNA integrity was assessed by electropherogram using a 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, California).  Total RNA (500 ng) from 
each sample was then amplified using an Epicentre® Biotechnologies (Madison, WI) 
TargetAmp™ 1-Round AminoallylaRNA Amplification Kit, yielding approximately 6-
10µg of aminoallyl-aRNA (AA-aRNA).  Alexa Fluor® 555-GREEN (Invitrogen, 
Carslbad, CA) was used to label the uninfected AA-aRNA, while Alexa Fluor® 647-
RED (Invitrogen) was used to label the AA-aRNA from the C. burnetii infected cells.  
Labeled AA-aRNA (2µg) with a dye incorporation efficiency range of 18 -34 
picomol/microgram, were mixed pair-wise and hybridized overnight to Human 
OneArray™ microarrays (Phalanx Biotech Group, Palo Alto, CA).  Human OneArrays 
contain 32,050 oligonucleotides; 30968 human genome probes and 1082 experimental 
control probes formed as 60-mer sense-strand DNA elements.  Arrays were hybridized, 
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washed, and dried rapidly according to the manufacturer‟s instructions.  Six 
hybridizations for each condition set (CAM and mock treated) were performed with three 
biological and two technical replicates.  Signal intensity of the hybridized arrays were 
measured by ScanArray Express (PerkinElmer, Boston, MA, USA) and the images were 
processed using GenePix Pro version 4.0 (Axon, Union City, CA, USA).  The processed 
GenePix Pro 4.0 output was further analyzed using Loess-Global intensity dependent 
normalization through the GenePix Auto Processor 
(http://darwin.biochem.okstate.edu/gpap3/) as previously described [231-233].  
Normalized ratio values for each data point were averaged across the three biological 
replicates and two technical replicates.  Significant expression differences were defined 
as a P-value <0.05 and displayed as a fold change of ≥2 fold [42, 234].  The microarray 
data were deposited at the NCBI Gene Expression Omnibus (GEO) under the platform 
accession number GPL6254 and the series number GSE23665.  The biological function 
of the identified genes was determined bioinformatically by the Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) v6.7 (http://david.abcc.ncifcrf.gov/) 
[235] as well as by Ingenuity pathway analysis (Ingenuity® Systems, 
www.ingenuity.com).  This software identifies canonical pathways within gene sets using 
significant associations (P<0.05) calculated by Fisher‟s exact test and also by a ratio of 
the number of molecules from the experimental data set that maps to the pathway, 
divided by the total number of molecules that exists in that canonical pathway. 
Immunofluorescence microscopy.  Non-adherant THP-1 cells (CAM and mock 
treated) were analyzed by indirect immunofluorescent antibody (IFA) microscopy.  
Briefly, 1x10
5 
cells were cytocentrifuged onto poly-L-lysine coated slides for 2 minutes 
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at 1000 rpm using a Shandon Cytospin® 4 Cytocentrifuge (Thermo Scientific) [236].  
The cytospun THP-1 cells were air dried and immediately fixed using ice cold acetone 
for 30 seconds.  The fixed preparations were then washed with PBS and stained with a 
rabbit antibody against whole killed C. burnetii NMII (primary antibody) followed by a 
goat anti-rabbit IgG Alexa Fluor-488 (Molecular Probes, Eugene,OR) secondary 
antibody.  Host and bacterial DNA were also stained using 4‟,6-diamidino-2-
phenylindole (DAPI).  Microscopy was conducted using a Nikon Eclipse TE 2000-S 
microscope with a Nikon DS FI1 camera and NIS-ELEMENTS F 3.00 software.  
IMAGEJ version 1.42n (Wayne Rasband, NIH) was also used for image processing 
[207]. 
RT-qPCR analysis.  RT-qPCR was performed using gene-specific primers 
(shown in Additional file 1-Supplemental Table S1.I), and the SYBR Green Master Mix 
Kit (Applied Biosystems) on an Eppendorf Mastercycler® ep realplex (Eppendorf, 
Hamberg, Germany) following the manufacturer‟s recommendations.  Briefly, first strand 
cDNA was synthesized using random hexamers, 1µg of total RNA, and the SuperScript 
III First-Strand Synthesis System for RT-PCR (Invitrogen) as suggested by the 
manufacturer.  Oligonucleotide primers were designed using Primer3Plus [237-238].  The 
primer efficiency of each primer set was determined to be within the efficiency window 
for the 2
-ΔΔCT
 relative fold calculation method [239].  The human β-actin gene was used 
as the reference gene.  Paired T-Test was performed to identify statistical differences 





SPV morphology within CAM treated C. burnetii infected THP-1 cells.  As 
the transient inhibition of C. burnetii protein synthesis within infected THP-1 cells using 
CAM is pivotal to testing our hypothesis, we sought to confirm that morphological 
changes occur to the PV of infected THP-1 cells after transient CAM treatment in a 
manner consistent with that observed in other cell types [12].  Using phase contrast and 
IFA microscopy analysis, we assessed the effect of bacteriostatic levels of CAM 
(10µg/ml) on infected THP-1 cells during the log growth phase of the C. burnetii 
infectious cycle in order to coincide with subsequent microarray analysis.  Robust 
infections (≥90% infected cells) were produced using C. burnetii NMII at a genome 
equivalent MOI of 15.  Infections were either mock or CAM treated at 48 hours post 
infection (hpi), and then compared at 72 hpi.  Figure 3.2 shows both phase contrast 
(Figure 3.2 top panel) and IFA microscopy (Figure 3.2, middle and bottom panels) 
images representative of the C. burnetii NMII infection of THP-1 cells at 72 hpi.  
Multiple, large SPVs can be seen in the mock treated THP-1 infections, while smaller, 
dense PVs are observed in the CAM treated infections.  These results are in agreement 
with published findings where transient CAM treatment resulted in PV collapse in C. 
burnetii infected Vero cells [12].  Figure 3.2C-H shows a set of similarly treated 
infections visualized by IFA microscopy.  C. burnetii are visualized in green (Figure 3.2, 
C and F) and cell nuclei are stained in blue (Figure 3.2, D and G) and the images merged 
(Figure 3.2, E and H).  Comparing the mock and CAM treated images (Figure 3.2, C and 
F), a noticeable decrease in vacuole size and fluorescent intensity is observed, indicating 
the collapse of the SPVs within the CAM treated cells when compared to the large, SPVs 
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observed within the mock treated cells.  Comparisons of DNA samples harvested at 48 
hpi (prior to CAM treatment) and 72 hpi (after 24 h CAM treatment) using qPCR 
determined that these samples had similar C. burnetii genome equivalents, indicating that 
the 10µg/ml CAM concentration was acting bacteriastatically (data not shown).  In 
addition, removal of CAM from infected cells after the 24 h transient treatment resulted 
in the re-establishment of large, SPVs within 48 h as observed by phase contrast 
microscopy (data not shown).  Together, these data indicate that 10µg/ml of CAM is able 
to transiently arrest C. burnetii protein synthesis in the THP-1 cell infection model. 
Gene expression in mock and CAM treated infected vs. uninfected THP-1 
cells.  As outlined in Figure 3.1, two whole genome RNA microarray analyses were 
performed resulting in the generation of two separate global gene expression profiles.  A 
total of 784 THP-1 genes (Additional file 1-Supplemental table S1.A) were up- or down-
regulated ≥2 fold in mock treated infected vs. uninfected cells while a total of 901 THP-1 
genes (Additional file 1-Supplemental Table S1.C) were up- or down-regulated ≥2 fold in 
CAM treated infected vs. uninfected cells.  To identify the host cell functions affected by 
C. burnetii infection and proteins, these gene sets were annotated using DAVID.  A 
modified Fisher Exact P-Value test was used to measure gene-enrichment in annotation 
terms.  The top biological function assignments for the mapped genes (P< 0.05) 
expressed as the percentage of the 784 and 901 significant genes identified in the mock 
and CAM treated microarrays, respectively, are shown in Additional file 2-Supplemental 
Figure 3.1.  This figure aids in defining the prominent cell functions affected by C. 
burnetii infection and proteins.  Identified as affected cell functions under both conditions 
are immune response, cell migration, regulation of programmed cell death, intracellular 
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signaling cascades, regulation of cell proliferation, and cytoskeletal organization.  
Notable differences were observed in the percentage of genes involved with each of these 
functions under the mock treated and CAM treated conditions, indicating a role for C. 
burnetii proteins in changing gene expression in these pathways.  Other important host 
cell functions influenced under the mock treated condition are protein phosphorylation, 
lipid storage, gas homeostasis, cell-cell signalling, and cellular ion homeostasis.  While 
major cellular functions seen affected only in CAM treated infected THP-1 cells are cell 
cycle processes, cell activation, response to DNA damage, lipid (sterol and cholesterol) 
transport, positive regulation of cytokine biosynthetic processes, and regulation of nitric 
oxide biosynthetic processes.  Additional file 1-Supplemental Tables S1.E and S1.F list 
the host genes associated with each of these functions.  Out of the 784 host genes 
identified in the mock treated data set, 62 genes were not assigned function by DAVID‟s 
biological annotation coverage.  In the CAM treated infected vs. uninfected data set, 102 
out of the 901 host cell genes remained unassigned. 
To further define the prominent host cell pathways affected by C. burnetii 
infection and proteins, an Ingenuity pathway analysis (IPA) was performed on the 784 
and 901 significant genes identified in the mock and CAM treated microarrays, 
respectively.  IPA identifies the top canonical pathways represented in a group of genes.  
Additional file 1-Supplemental Tables S1.G and S1.H list the top canonical pathways 
associated with the mRNA profiles of the mock treated and CAM treated infected vs. 
uninfected THP-1 cells, respectively.  From the mock treated microarray set, 17 
biological functions were influenced by infection while 28 functions were significantly 
affected by CAM treatment of infections (Additional file 1-Supplemental Tables S1.E 
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and S1.F).  Many of the biological functions identified are the result of the molecular 
pathways identified by IPA, with several innate immune response and stress pathways 
implicated when C. burnetii protein synthesis is arrested, again indicating a role for C. 
burnetii proteins in managing the host cell response to infection. 
Comparative analysis between mRNA profiles of untreated and CAM 
treated uninfected/infected THP-1 cells.  In order to identify the host cell genes 
differentially expressed (≥2 fold) in response to de novo C. burnetii protein synthesis, we 
compared the two separate mRNA expression profiles.  Microarray analysis of mock 
treated (-CAM), uninfected vs. infected THP-1 cells using a broad cut-off of >0 fold 
revealed a gene summary list of 2557 genes (P<0.05) (Additional file 1-Supplemental 
Table S1.B).  Within this data set are the 784 genes which changed ≥2 fold (S1.A), and 
was considered a significant change.  Using a >0 fold cut-off for the CAM treated 
(+CAM) uninfected vs. infected THP-1 cells, a gene summary list of 2584 genes were 
identified (Additional file 1-Supplemental Table S1.D).  The subset of 901 genes that 
changed significantly (≥2 fold, S1.B) was within this large gene summary list.  Figure 3.3 
depicts a comparison of these two sets of microarray data using Venn diagrams.  To 
eliminate the insignificantly (<2 fold) expressed genes, (i) the subset of significant THP-
1–CAM genes (784) was cross-matched to the THP-1+CAM whole gene summary list 
(>0 fold) of 2584 genes and, (ii) the subset of significant THP-1+CAM genes (901) was 
cross-matched to the THP-1–CAM whole gene summary list (>0 fold) of 2557 genes.  
This cross comparison identified 28 genes in the THP-1-CAM subset and 35 genes in the 
THP-1+CAM subset that were significantly changed (≥2 fold) between the two 
microarray conditions.  The overlapping genes from these two data sets were pooled (27 
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genes) and uniquely expressed genes in the -CAM (1 gene) and +CAM (8 genes) were 
identified.  Comparing the results from these two gene subsets provided us with a list of 
36 candidate host cell genes whose expression was ≥2 fold different between the mock 
treated (–CAM) and CAM treated (+CAM) arrays, indicating genes whose expression is 
modulated by de novo synthesized C. burnetii proteins. 
Host cell biological functions associated with THP-1 mRNAs modulated by 
de novo C. burnetii protein synthesis.  To determine the host cell biological pathways 
being affected by C. burnetii protein synthesis, IPA was used.  Analysis of the subset of 
thirty-six differentially expressed host genes modulated by C. burnetii protein(s) were 
classified according to the biological function they are associated with, the protein‟s 
cellular location, and its molecular function (Table 3.1).  A majority of the proteins in this 
data set are predicted to reside in the cytoplasm (14 proteins) and cell nucleus (9 
proteins).  Six proteins are predicted to function in the extracellular space while four 
proteins are thought to be located on the plasma membrane.  Other than cellular location, 
the host genes were also categorized on the basis of the expressed protein‟s function – i.e. 
enzyme, cytokine, transporter, transcriptional regulator, or other.  For the thirty-six gene 
subset, Table 3.1 also lists the fold change found within the separate mock treated and 
CAM treated microarrays, respectively, as well as the fold difference between the arrays.  
C. burnetii infected host cells had lower RNA levels of twenty-two host genes relative to 
cells containing C. burnetii transiently inhibited with CAM.  RNA levels of fourteen 
genes in this data set are found to be higher due to C. burnetii infection when compared 
to the CAM treated condition.  Bioinformatic analysis conducted to determine possible 
biological functions of these C. burnetii modulated host genes indicates that immune 
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response and cellular movement, cellular signaling, cellular proliferation, cell death, lipid 
metabolism, molecular transport, as well as vesicle trafficking, and cytoskeletal 
organization are affected by C. burnetii protein synthesis (Table 3.1).  These data indicate 
that the expression of vital genes involved in cellular movement - IL8, CCL2, CXCL1, 
SPP1 (cytokines) are suppressed via C. burnetii’s protein synthesis in mock treated 
conditions when compared to CAM treated conditions.  These secretory molecules (IL8, 
CCL2, CXCL1, SPP1) regulate the infiltration and trafficking of immune cells.  Table 3.1 
shows other crucial host genes specifically suppressed by C. burnetii protein synthesis in 
THP- 1 infection such as BCL3, CTSB and CTSL1 (apoptosis), MTSS1, SMTN and 
PLEKHO1 (cytoskeleton organization), APOE, PLIN2 and FABP4 (lipid metabolism), 
and RAB20, SOD2, PSMA8, MSC, ZFP36L1, and RORA (Miscellaneous).  The 
prominent genes found to be up-regulated (induced) due to C. burnetii‟s protein synthesis 
are ITK, DUSP9 & SKP2 (intracellular signaling), SOX11, HELLS & PGR (cell growth 
and proliferation) SLC22A6, CDH2, PSD4, ZNF573, CHMP5 & MRPL44 
(Miscellaneous) and ANLN (cytoskeleton organization). 
RT-q PCR analysis of THP-1 gene expression in response to mock and CAM 
treated C. burnetii infection.  RT-qPCR was used to validate the expression trends of 
selected genes identified by microarray analysis.  Using the same total RNA samples 
utilized for the microarray hybridizations, six host genes were selected (IL8, CCL2, 
ZFP36L1, APOE, RND3, and POU4F2) and analyzed by RT-qPCR using the 
constitutively expressed β-actin gene as a comparative control.  In each case, the RT-
qPCR data matched the trends from the microarray analysis with respect to whether 
expression was increased, decreased, or unchanged.  Figure 3.4 shows the fold expression 
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differences of IL8, CCL2, ZFP36L1, APOE, RND3, and POU4F2 identified by 
microarray in mock and CAM treated experimental conditions (Figure 3.4A) and the 
subsequent RT-qPCR analysis (Figure 3.4B).  IL8, CCL2, APOE, and ZFP36L1 
represent genes that are increased in mock treated C. burnetii infected THP-1 cells but 
increase further when C. burnetii’s protein synthesis is transiently inhibited using 
bacteriostatic levels of CAM.  The POU4F2 gene expression is decreased similarly under 
both conditions and represents a THP-1 gene modulated by C. burnetii infection whether 
or not active protein synthesis is occurring.  RND3 expression increases similarly in C. 
burnetii infected THP-1 cells regardless of ongoing bacterial protein synthesis.  These 
results confirm that genes with significant mRNA expression changes by oligonucleotide 
microarrays analysis are differentially expressed when measured by RT-qPCR. 
Discussion 
Bacterial effector proteins are crucial to the survival and growth of intracellular 
pathogens within the eukaryotic cellular environment.  These interactions may be at a 
myriad of pathways or at points within a single pathway.  Moreover, the growth of C. 
burnetii within the lumen of the PV would require the mediation of interactions with the 
host cell using effector proteins, which are predicted to be delivered by the pathogen‟s 
type IV secretion system [18, 44, 210].  The goal of this study was to identify host genes 
that are specifically manipulated by C. burnetii proteins.  Our hypothesis was that the 
expression of host cell genes will be changed by infection with C. burnetii NMII and that 
the expression of a subset of these genes will be directly affected by ongoing bacterial 
protein synthesis.  Identification of such genes will aid in the understanding of host 
molecular mechanisms being targeted by C. burnetii during growth.  In order to identify 
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the host genes regulated by C. burnetii proteins, we compared CAM and mock treated 
mRNA profiles of THP-1 cells following a 72 h infection with C. burnetii.  Microarray 
data analysis shows that the majority of host genes were up- or down regulated similarly 
in both the mock and CAM treated array sets, suggesting that most THP-1 genes were not 
differentially modulated at the RNA level by active C. burnetii protein synthesis.  We had 
predicted that the majority of expression changes in the host cell would be in response to 
the physical presence of bacteria within the cell.  Using stringent analysis conditions, the 
transcriptional response data comparisons identified thirty-six differentially expressed 
genes, which were uniquely modulated by C. burnetii proteins.  The targeting of these 
host genes by the pathogen indicates they may fall within pathways that C. burnetii needs 
to modulate for its own survival. 
During infection C. burnetii replicates intracellularly, which aids in avoidance of 
the host immune response.  Immune clearance of bacteria is largely dependent on cellular 
sensors called pattern recognition receptors (PRR) found on phagocytes [27].  Activated 
macrophages then eliminate bacteria through extrinsic or intrinsic apoptosis and/or 
inducing pro-inflammatory cytokines [27].  Bacteria employ indirect mechanisms to 
regulate cytokine production by interfering with the NFkappaB signaling pathway, which 
is a potent transcriptional activator of cytokines. [240].  Interestingly, of the thirty-six 
host genes that met our criteria (Table 3.1) for C. burnetii protein driven expression 
changes, four are cytokines (IL8, CCL2, CXCL1 and SPP1).  These secretory molecules 
are noted for chemo-attraction of phagocytic and lymphocytic cells [241-243].  C. 
burnetii protein(s) appear to reduce the RNA levels of each of these four genes in 
infected THP-1 cells relative to those found in infected cells transiently inhibited with 
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CAM.  The ability of C. burnetii to avoid or suppress host cytokine signalling, even 
transiently, may well represent an essential part of its ability to survive and cause disease 
by preventing communication between innate and adaptive immune cells. 
Although the control and clearance of C. burnetii infection is T-cell dependent, 
specific data on T-cell activation signals are lacking [23].  One study indicated that an in 
vitro stimulation of peripheral blood mononuclear cells (PBMC) by virulent and avirulent 
C. burnetii strains cause the production of RANTES and CCL2 [41].  Using a 36 h model 
of C. burnetii infection, a DNA microarray study reported an increase in host cell 
expression of certain chemokines (RANTES, SCYA3, SCYA4, and IL8).  The study also 
observed no induction of TNF-α and IL-1β after 36 h of infection, but the antimicrobial 
response gene encoding cytochrome b-245 (CYBB) was up-regulated [42].  In the current 
study, IL8 gene expression was also increased due to C. burnetii infection but expression 
was further increased when C. burnetii protein synthesis was inhibited, suggesting that 
bacterial protein(s) differentially modulate the expression of IL-8 during infection.  In 
addition, the IL8 receptor gene (IL8RB) was found to be down regulated in mock treated, 
infected THP-1 cells (see Additional file 1-Supplemental Table S1.A).  This is the first 
evidence of host cell cytokine production being modulated by C. burnetii protein during 
an infection.  
In addition to the immune response, C. burnetii has to overcome another central 
host defense mechanism, apoptosis.  The intracellular pathogens C. trachomatis, 
Mycobacterium tuberculosis as well as C. burnetii posses mechanisms to subvert cell 
death pathways [19-20, 244-245].  C. burnetii has been shown to inhibit host cell 
apoptosis by a mechanism that prevents cytochrome C release from the mitochondria 
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[20].  C. burnetii directs the sustained activation of host pro-survival kinases Akt and 
Erk1/2, which are necessary for anti-apoptotic activity [19] .  Table 3.1 shows that seven 
of the thirty-six C. burnetii protein modulated THP-1 genes are associated with apoptosis 
and cell proliferation within eukaryotic cells.  C. burnetii protein(s) suppress the 
expression of three genes (BCL3, CTSB, and CTSL1), when compared to expression 
levels present in CAM treated THP-1 cells, which can have pro-apoptotic activities.    By 
modulating these host genes during infection C. burnetii appears to promote its own 
survival by ensuring the survival of the host cell.  The expression of the four cell 
proliferation/survival genes (C11ORF82, PGR, SOX11 and HELLS) are significantly 
reduced when C. burnetii’s protein synthesis is inhibited during infection of THP-1 cells 
(Table 3.1).  The expression of each of these genes is higher in infected cells than in 
infected cells where bacterial protein synthesis is inhibited, again indicating that C. 
burnetii protein(s) have an anti-cell death affect.  Interestingly, our microarray analysis 
also shows a 4-fold expression decrease of TNFRSF10A (Death receptor 4) in mock 
treated infections of THP-1 cells (Additional file 1-Supplemental Table S1.A).  
Normally, TNFRSF10A induces apoptosis by binding to TNFSF10/TRAIL ligand in cells 
[246], suggesting that the expression changes in C. burnetii infected cells may represent 
another means of inhibiting host cell death. 
 Eukaryotic host cell cytoskeleton (actin filaments, microtubules and intermediate 
filaments) are a common target of molecular interactions for intracellular microbial 
pathogens [22].  Virulent C. burnetii has been shown to affect F-actin reorganization in 
THP-1 cells [199-200].  F-actin has also been shown to be associated with PV formation 
and homotypic fusion of C. burnetii containing vacuoles, although PVs are able to 
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acquire lysosomal markers when F-actin formation is inhibited [215].   Our analysis 
indicates that MTSS1, ANLN, SMTN and PLEKHO1 are differentially modulated by C. 
burnetii protein synthesis (Table 3.1).  Compared to CAM treated THP-1 infections, the 
relative expression levels of MTSS1, SMTN and PLEKHO1 is lower in THP-1 mock 
treated infections.  The relative expression of ANLN is higher in mock treated C. burnetii 
infections than in CAM treated infections.  Interestingly, ANLN interacts with F-actin 
and is over expressed in dividing cells[247], suggesting that C. burnetii infection supports 
cell growth and division.   The structure and integrity of the PV as well as host cell 
vesicles fusogenicity with the PV is dependent on cytoskeletol structures[215].  Finding 
that four out of the thirty-six genes are associated with the regulation and function of the 
cells cytoskeleton supports findings that the cytoskeleton is crucial to C. burnetii during 
infection. 
 Manipulation of cellular lipids is emerging as an important factor in infectious 
diseases [248-249].  Host cell cholesterol levels affect the growth of intracellular 
bacterial pathogens such as Salmonellae, Mycobacteriae, Brucellae, Anaplasma, and 
Coxiellae [218, 249].  Little is known about cholesterol levels or imbalance in Q-fever 
patients, but studies at the cellular level indicate that C. burnetii infected Vero cells 
contain 73% more cholesterol than uninfected cells[218].  Table 3.1 lists three C. burnetii 
protein(s) modulated host genes (APOE, PLIN2, and FABP4) that are associated with 
lipid metabolism and regulation.  These genes have lower relative expression levels in the 
mock treated THP-1 infections when compared to the CAM treated THP-1 infections.  
APOE is a multifunctional protein primarily involved in cholesterol homeostasis [250-
254].  Endogenously, APOE promotes cholesterol efflux in macrophages to lower 
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intracellular cholesterol concentrations.  Macrophages deficient in APOE are severely 
compromised in cholesterol homeostasis [250-254].  PLIN2  and fatty acid binding 
protein 4 (FABP4) are proteins that associate with lipids and fatty acids, respectively, and 
mediate the stabilization of lipid droplets and fatty acid transport [255-256].   An increase 
in cholesterol regulating proteins would be expected in response to the profound 
increases in the cellular concentration of cholesterol seen during C. burnetii infection.  
This makes the increase in APOE expression observed upon inhibition of C. burnetii 
protein synthesis particularly noteworthy.  It seems that modulation of these key lipid 
homeostasis genes allows C. burnetii to not only suppress the loss of host cell cholesterol 
but to also direct lipid trafficking. 
 Bacterial pathogens often subvert host cell signaling pathways by introducing 
bacterial effector proteins that interfere with host cell phophorylation cascades [22].  C. 
burnetii dependent regulation of host cell signal transduction pathways are not well 
understood.  Our data identified active modulation of three host cell signal transduction 
genes (ITK, DUSP9 and SKP2) by C. burnetii’s protein(s).  While ITK and SKP2 play 
significant roles in inducing host cell proliferation [257-258], DUSP9 is a mitogen-
activated protein kinase phosphatase (MKP) that negatively regulates MAPK activity in 
mammalian cells, thus preserving the cell from apoptosis [259].  The expression of these 
genes are relatively higher in C. burnetii infected THP-1 cells compared to the expression 
levels found in C. burnetii infected THP-1 cells transiently inhibited by CAM.  This 
suggests that C. burnetii protein synthesis “encourages” cell proliferation in addition to 
its anti-apoptotic effects as a means to preserve the host cell environment. 
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 In addition to the outlined host cell processes, we identified a variety of genes 
involved in diverse functions of a host cell, which were also modulated by C. burnetii 
protein synthesis (Table 3.1).  In this miscellaneous cellular functions category, some 
genes were expressed at relatively higher levels than what was expressed in CAM 
inhibited infected cells and are of particular interest.  The PSD4 gene, which is involved 
in membrane recycling [260], and CHMP5, which is an essential regulator of late 
endosome function.  CHMP5 null cells show enhanced signal transduction, protein 
accumulation in enlarged multi vesicular bodies (MVB) and inhibition of MVB 
trafficking to lysosomes [261].  In addition, we have recently found that markers of multi 
lamellar/multi vesicular bodies associate with membrane structures within the PV lumen 
during C. burnetii infection of Vero cells (unpublished observations).  Given that C. 
burnetii’s replication niche possesses markers consistent with those on late 
endosomes/lysosomes [3], our finding that expression of these genes are markedly lower 
when C. burnetii protein synthesis is inhibited suggests that they play a part in 
development and maintenance of the PV during infection.  This overall manipulation of 
endocytosis, vesicle trafficking, and late endosome/lysosome maturation is in agreement 
with studies which found that inhibition of C. burnetii protein synthesis at any point 
during the life cycle changes these processes within C. burnetii infected cells [12-13]. 
Conclusions 
Through this study we have discovered thirty-six host cell genes with significant relative 
expression changes after transient inhibition of C. burnetii protein synthesis.  The 
expression changes of these genes in the mock and CAM treatment conditions were 
confirmed using RT-qPCR analysis.  Using bioinformatics, we have also determined the 
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predominant host cell processes associated with these genes.  Collectively, these data 
support our hypothesis that C. burnetii proteins differentially modulate host cell genes 
during infection.  Predominant cellular functions that are modulated by C. burnetii 
proteins include (i) innate immune response, (ii) cell death and proliferation, (iii) vesicle 
trafficking and development, (iv) lipid homeostasis, and (v) cytoskeletal function.  These 
findings indicate that C. burnetii actively modulates the expression of genes that may 
play a role in the ability of the pathogen to establish the PV, survive, and replicate within 
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  CTSB Cytoplasm  peptidase 3.102 6.565 ↑3.463 
Apoptosis  CTSL1 Cytoplasm  peptidase 3.173 6.914 ↑3.741 
  BCL3 Nucleus  transcription regulator 3.103 5.673 ↑2.57 
  C11ORF82 Cytoplasm  other -1.849 -4.912 ↓3.062 
Cell  SOX11 Nucleus  transcription regulator 3.127 -2.915 ↓6.042 
proliferation  HELLS Nucleus  enzyme -1.551 -4.653 ↓3.101 
  PGR Nucleus  ligand-depend. nuclear recept. -1.539 -6.853 ↓5.313 
  ITK Cytoplasm  kinase 2.752 -2.46 ↓5.212 
Cell signaling  DUSP9 Nucleus  phosphatase -2.04 -4.388 ↓2.348 
  SKP2 Nucleus  other 1.581 -2.627 ↓4.208 
  MTSS1 Cytoplasm  other 4.389 6.986 ↑2.597 
Cytoskeleton  ANLN Cytoplasm  other -1.943 -4.679 ↓2.735 
  SMTN Extracell. space  other -3.319 4.006 ↑7.325 
  PLEKHO1 Plasma memb.  other 2.162 5.396 ↑3.234 
  SPP1 Extracell. space  cytokine 3.351 6.733 ↑3.382 
Immune   CCL2 Extracell. space  cytokine 5.053 7.451 ↑2.398 
response  CXCL1 Extracell. space  cytokine 5.221 7.275 ↑2.054 
  IL8 Extracell. space  cytokine 7.839 9.985 ↑2.146 
  FABP4 Cytoplasm  transporter 2.351 4.506 ↑2.155 
Lipid   APOE Extracell. space  transporter 2.591 4.958 ↑2.367 
metabolism  PLIN2 Plasma memb.  other 3.725 5.772 ↑2.047 
  RAB20 Cytoplasm  enzyme 2.489 4.925 ↑2.436 
  FAM177B Unknown  other 5.064 7.125 ↑2.061 
  SELM Cytoplasm  other -2.23 2.531 ↑4.761 
  PSMA8 Cytoplasm  peptidase -2.494 3.212 ↑5.706 
  MSC Cytoplasm  transcription regulator 3.17 5.49 ↑2.32 
  MRPL44 Cytoplasm  enzyme 2.775 -1.356 ↓4.131 
Miscelleaneous  CHMP5 Cytoplasm  other 1.525 -2.189 ↓3.714 
  RORA Nucleus  ligand-depend. nuclear recept. -6.756 7.147 ↑13.903 
  ZFP36L1 Nucleus  transcription regulator 3.815 6.842 ↑3.027 
  ZNF573 Nucleus  other 1.412 -3.322 ↓4.734 
  SLC22A6 Plasma memb.  transporter 2.097 -2.146 ↓4.243 
  CDH2 Plasma memb.  other -1.626 -3.634 ↓2.007 
  KIAA1279 Unknown  enzyme 7.811 12.888 ↑5.077 
  SPATA6 Unknown  other -2.473 19.906 ↑22.379 
  PSD4 Unknown  other 2.197 -2.149 ↓4.346 
1
 Fold change of expressed THP-1 genes in response to C. burnetii infection under mock treated condition. 
2
 Fold change of expressed THP-1 genes in response to C. burnetii infection under CAM treated condition. 
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Figure 3.1.  Diagram of the experimental design for comparative C. burnetii infected 
host-cell microarrays.  The rows of the top panel are untreated and rows of the bottom 
panel are treated with CAM (10µg/ml) at 48h hpi.  Total RNA harvests are performed at 





Figure 3.2.  Phase contrast and fluorescent microscopy of C. burnetii infected THP-1 
cells.  All images are of C. burnetii infected THP-1 cells 72 hpi.  Top Panel, Phase 
contrast microscopy.  A, a mock treated infection.  B, infection treated with 10 μg/ml 
CAM for the final 24 h.  Arrows indicate PVs.  Middle Panel, IFA microscopy images of 
a mock treated infection.  C,  Alexa-488 staining of C. burnetii.  D,  DAPI staining.  E,  
merge of C and D.  Bottom Panel, IFA microscopy images of an infection treated with 
10 μg/ml CAM for the final 24 h.  F,  Alexa-488 staining of C. burnetii.  G,  DAPI 




Figure 3.3.  Venn diagram of differentially expressed THP-1 genes.  A venn diagram 
visualization showing 784 and 901 differentially expressed host genes in C. burnetii 
infected THP-1 cells under mock (- CAM) and CAM treated (+ CAM) conditions 
respectively, as determined by oligonucleotide microarray analysis.  Comparisons 
between differentially expressed genes of –CAM with the gene summary list of + CAM 
(>0 fold Δ = 2584 genes) and differentially expressed genes of + CAM with the gene 
summary list of –CAM (>0 fold Δ = 2557 genes) are also shown.  The intersections 
(areas of overlap) indicate genes regulated in common under both conditions.  Twenty-
eight of the differentially expressed genes in - CAM and thirty-five of the differentially 
expressed genes in + CAM are modulated by C. burnetii protein synthesis (>2 fold 
difference).  Of these, twenty-seven are common between the two conditions, while eight 
and one genes are uniquely expressed in +CAM and –CAM conditions, respectively.  
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Figure 3.4.  RT-qPCR of selected genes confirms microarray expression trends.  A, 
shows the microarray data of the genes used to confirm microarray expression trends.  
Fold difference (-CAM) is the fold change of differentially expressed THP-1 genes in 
response to C. burnetii infection after mock treatment.  Fold difference (+CAM) is the 
fold change of differentially expressed THP-1 genes in response to C. burnetii infection 
after CAM treatment.  B, difference in mRNA levels in selected genes relative to β-actin.  
An equal amount of total RNA from each sample was analyzed by RT-qPCR.  The Y-
axis represents fold changes in gene expression while X axis shows the conditions under 
which gene expression was observed (mock and CAM treated, and uninfected and C. 
burnetii infected THP-1 cells). U–CAM, uninfected THP-1 minus CAM. U+CAM, 
uninfected THP-1 plus CAM.  I–CAM, infected THP-1 minus CAM.  I+CAM, infected 
THP-1 plus CAM.  The results represent the mean of three biological samples and three 
technical replicates of each sample.  Error bars represent the s.e.m.  
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Additional file 1  
http://www.biomedcentral.com/1471-2180/10/244/additional/ 
Tables S1.A-I. Excel file containing Tables S1.A through S1.I as individual tab-
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Figure S1. Biological function assignments of genes differentially expressed in mock 
and CAM treated THP-1 cells infected with C. burnetii.  Both sets of microarray data 
(Additional file 1-Supplemental Tables S1.A and S1.B) containing differentially 
expressed genes for mock and CAM treated C. burnetii infections of THP-1 cells were 
annotated using DAVID to extract the biological functions of the listed genes.  The X 
axis shows the percentage of differentially expressed genes associated with each 
annotation term while the Y axis shows the prominent biological functions (annotation 
terms) obtained through functional annotation of the differentially expressed genes.  P-
values for each annotation term are calculated using modified Fisher‟s exact test.  A P-
value cut off 0.05 or less has been used to identify biological functions.  Top panel, 
shows the common host cell functions regulated under both conditions (mock and CAM 
treatment).  Middle panel shows the major cellular functions affected only in C. burnetii 
infected THP-1 cells undergoing mock treatment.  Bottom panels show the crucial host 








COXIELLA BURNETII MODULATES NF-κB ACTIVATION IN HUMAN THP-1 






Coxiella burnetii, is an obligate intracellular pathogen and the causative agent of 
acute Q fever as well as chronic disease in humans[4, 52].  C. burnetii infects alveolar 
macrophages and replicates within parasitophorous vacuoles (PV) resembling 
phagolysosomes while evading the host immune system [3, 23].  The C. burnetii 
infectious/life cycle is ~6 days long [172] and is highlighted by invasion of the host cell, 
development of the acidified PV (pH<5), differentiation of C. burnetii small cell variant 
(SCV) forms to large cell variants (LCVs), PV enlargement, log growth of the pathogen, 
an asynchronous LCV to SCV differentiation, and eventual cell lysis [3, 172]. C. burnetii 
is environmentally stable, acquired through aerosolization, has a low infectious dose 
(ID50) [185], and classified as a category B select agent [52, 58].  Acute Q fever usually 
manifests as a self-limiting flu-like illness, with symptoms ranging from sub-clinical to 
debilitating and can be fatal [4].  Common chronic sequelae include endocarditis, 
hepatitis, and/or a chronic fatigue syndrome [5-6].  In many countries, C. burnetii 
infection of heart valves is a leading cause of culture-negative endocarditis [7]. 
Disease often occurs due to the ability of pathogens to subvert the immune system 
and modulate other cellular processes of the host. Manipulation of host nuclear 
transcription factor NF-κB signaling pathway(s) is a common strategy used by microbial 
pathogens to thwart hosts cellular defense responses [22].  NF-κB is a vital regulator of 
genes involved in pro-inflammatory immune response, cell proliferation, and apoptosis 
[262].  Normally, NF-κB transcription factors - p50 (NF-κB1), p52 (NF-κB2), p65 
(RelA), cRel, and RelB remain in the cytoplasm bound to the IκB inhibitory protein.  
These factors are activated via the canonical, non-canonical, or IKK independent 
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(Atypical) signaling pathways [262-263].  In either case, NF-κB activation and nuclear 
accumulation leads to inflammatory and immunomodulatory responses  [262-263].  In 
general, humans first counter invading microbial pathogens by triggering innate immune 
inflammatory responses which are typically mediated via rapid activation of NF-κB [264] 
and subsequent expression of pro-inflammatory cytokine genes [29, 262, 265-266].  
However, C. burnetii seems to employ unknown mechanisms to successfully avoid host 
innate immune and other cellular defense mechanisms [19, 23].  It is likely that the  type 
IV secretion system (T4SS) possessed by C. burnetii allows for the release of  C.burnetii 
effector proteins, which are used to manipulate eukaryotic cellular functions [18]. 
However, little or no information exists about the regulation of host immune signaling 
pathways being targeted by C. burnetii during the course of infection. 
In order to determine if C. burnetii triggers host innate immune response, the role 
of Toll like receptors (TLRs) have been analyzed [36].  Activated TLRs usually signal 
through the NF-κB signaling pathway [264].  Studies indicate that TLR2 plays a crucial 
role in C. burnetii phase II recognition.  It was observed that C. burnetii infected TLR2 
deficient macrophages fail to produce inflammatory cytokines IL-12 and TNF-α [36];  
however, C. burnetii surface molecules which activate TLR2 remain undefined.  The 
stimulation of Toll-like receptor 4 (TLR4) in mammalian macrophages induces the 
release of critical pro-inflammatory cytokines.  As TLR4 is typically activated by 
bacterial LPS [267], the role of TLR4 in C. burnetii infection has also been examined.  
Data shows that upon C. burnetii infection macrophages deficient for TLR4 produce 
elevated amounts of IL-12 and TNF-α.  In addition, TLR4 knockout mice effectively 
arrests C. burnetii infection [37].  It seems unlikely that C. burnetii signals through TLR4 
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but one study reports that TLR4 has an association with initial pathogen uptake [37].  
Interestingly, experiments on DC maturation using C. burnetii NMI and NMII strains 
show that phase I but not phase II C. burnetii prevents macrophage and DC maturation 
[38].  However, investigations also reveal that LPS chemotypes are not responsible for 
DC maturation or cytokine production [40]. Hence, it appears that phase I C. burnetii 
uses unknown mechanisms to prevent DC maturation. 
Even though the innate immune system is unable to contain primary infections by 
C. burnetii, cytokine production is commonly reported [122].  C. burnetii has been shown 







 phenotype with a variable capacity to produce inflammatory 
chemotactic cytokines [39, 224].  Reports reveal the induction of several other cytokines 
during C. burnetii infection [41, 268].  These include RANTES and MCP-1, SCYA3, 
SCYA4, and IL8 [42].  The role of IL10 has been extensively studied in chronic Q-fever 
patients as it has been implicated in the enhanced persistence of C. burnetii in infected 
hosts due to its anti-inflammatory properties [225].  Experiments also show that C. 
burnetii phase II but not C. burnetii phase I stimulates increased IL-12 and TNF 
production [38].  Additionally, C. burnetii actively inhibits apoptosis to sustain its host 
cell [19-20].  However, these studies do not indicate if the cytokine or anti-apoptotic 
responses during C. burnetii infection arise in a NF-κB dependent manner.  It is also 
unknown if NF-κB signaling is being actively modulated by C. burnetii proteins during 
infection. 
The fact that C. burnetii infects, grows and replicates within alveolar 
macrophages which are characteristically responsible for phagocytosis and killing of 
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invading pathogens [269-270] suggests the bacterium is capable of overcoming the 
mononuclear phagocytes detection and pro-inflammatory response mechanisms.  
Previously, we used comparative microarray analysis, RT-qPCR and transient inhibition 
of bacterial protein synthesis to discover a subset of inflammatory cytokine genes (IL8, 
CCL2, CXCL1, and SPP1), [271] the expression of which are classically mediated 
through the NF-κB signaling pathway [22, 262, 272].  These secretory molecules 
normally regulate the infiltration and trafficking of immune cells [273].  C. burnetii 
protein(s) actively reduced the RNA levels of each of these genes relative to those found 
in cells containing bacteria transiently inhibited with chloramphenicol (CAM) [271].  
Here, we hypothesized that the distinct suppression of cytokine genes may be a result of 
C. burnetii‟s ability to modulate NF-κB activation in host cells.  Modulation of genes 
regulated by NF-κB may represent a crucial step in C. burnetii’s virulence.  Furthermore, 
C. burnetii‟s intracellular survival and growth may also depend on its ability to 
manipulate molecular components of this signaling pathway.  In this study, we have 
analyzed C. burnetii induced modulation of NF-κB signaling and also defined the 
temporal modulation of NF-κB activation throughout its infectious cycle.  In addition, we 
have also examined whether more than one of the NF-κB signaling pathways participate 
in NF-κB activation durign C. burnetii infection of host cells. 
Material and Methods 
Growth of C. burnetii, tissue culture and infection:  C. burnetii Nine mile 
phase II strain was cultivated in African green monkey kidney Vero cells (CCL-81; 
ATCC, Manassas, VA) and purified as previously described [207].  Human monocytic 
leukemia derived THP-1 cells (TIB-202; ATCC) were grown in 75-cm
2
 tissue culture 
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flasks using RPMI 1640 medium (Gibco, Carlsbad, CA) supplemented with 1 mM 
sodium pyruvate, and 10% fetal bovine serum (FBS) at 37°C in 5% CO2 [271].  
Synchronous infections with C. burnetii phase II strains were initiated in 24-well tissue 
culture plates at a multiplicity of infection (MOI) of 25.  Bacteria were added to 2 x 10
6
 
THP-1 cells per well in a total volume of 1ml and incubated at 37°C for 4 hours to allow 
close host cell-bacteria contact.  Another 1ml of fresh media was added to the cells after 
4 hours to bring the final concentration to 10
6
 cells/ml (this time point represents T = 0).  
To determine whether C. burnetii modulate host cell NF-κB activation during infection, 
experiments were first performed with uninfected or C. burnetii infected THP-1 cells at 
72 hpi (exponential phase) for total protein extraction.  Cells were then incubated in 
media with (+CAM) or without (-CAM) bacteriastatic levels (10µg/ml) of 
chloramphenicol (CAM) for the final 24 h of infection [271].  Table 4.1 outlines the 
experimental design used to assess the temporal modulation of host cell NF-κB during 
the entire course of infection by C. burnetii.  Experiments were performed in parallel, 
with mock treated and chloramphenicol (CAM) treated sets as published previously 
[271].  At various times post infection (PI) (0, 24, 48, 72, 96, and 120 hpi), one 
experimental set was transiently treated with 10µg/ml (bacteriostatic) of CAM for 24h 
while the other set was mock treated.  Cell culture media was exchanged daily using 
centrifugation to harvest the cells and removal of the spent media followed by suspension 
of the cells in fresh media with or without CAM (10µg/ml).  Infected and uninfected cells 
were handled identically and a minimum of three experiments (n=3) was carried out for 
each time point and condition.  As a control, tumor necrosis factor alpha (TNFα; BD 
 
 82 
Biosciences, San Jose, CA) was added to cell cultures at a final concentration of 50 ng/ml 
for 8h prior to harvest in order to induce NF-κB activation [19]. 
Western blot analysis:  Collected THP-1 cell pellets were directly lysed in 100µl 
of 2X laemmli sample buffer (Bio-Rad, Hercules, CA) along with protease and 
phosphotase inhibitors (Sigma).  Samples were then separated by 12% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane 
(Pierce, Rockford, IL).  The membranes were blocked for an hour at room temperature 
with 5% nonfat milk in Tris-buffered saline (150 mM NaCl, 100 mM Tris-HCl, pH 7.6) 
containing 0.1% Tween-20 (TBST) [19].  Following blocking, membranes were 
incubated overnight at 4°C with 5% nonfat milk in TBST having primary antibodies for 
target proteins.  Detection of NF-κB activation was carried out using the rabbit 
monoclonal anti-human primary antibody specific to the phosphorylated Serine 536 form 
of NF-κB p65 (Cell Signaling Technology, Danvers, MA), and rabbit anti-human 
polyclonal antibody against p100 (the precursor), and p52, the active form of NF-
kappaB2 (Cell Signaling Technology, Danvers, MA).  Mouse monoclonal antibodies 
directed against human β-actin (Sigma, Saint Louis, MO) were also employed to detect 
host cell β-actin (used as a loading control).  Nitrocellulose membranes were then washed 
using TBST and incubated with anti-rabbit or anti-mouse IgG secondary antibody 
conjugated to horseradish peroxidase (KPL, Gaithersburg, MD) for 1h at room 
temperature.  After incubation membranes were washed and target proteins were detected 
by enhanced chemiluminescence using ECL SuperSignal West Pico Chemiluminescent 
Substrate (Pierce, Rockford, IL).  Visualization and digital imaging of the blots was 
performed on a FluorChem HD2 Imaging System (Alpha Innotech Corporation, Leandro, 
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CA).  The signal density of the detected bands in experimental samples were analyzed by 
ImageJ [274]. 
Results 
NF-κB activation is modulated by C. burnetii proteins during infection.  
Among all the members of NF-κB complex, p65 is one of the most extensively studied 
subunits.  Additionally, like cRel, and RelB, it contains both a 300-amino acid region 
with homology to the Rel proto-oncogene (RH domain) and the transactivation domain 
[262, 275-276].  The RH domain harbors motifs for nuclear localization, and binding to 
specific DNA sequences while the transactivation domain, which remains bound to the 
inhibitor IκB in cytoplasm, contains phosphorylation sites [262, 277].  Phosphorylation 
of the S536 site in the transactivation domain is required for optimal activation [262, 276-
277].  In an effort to determine whether host cell NF-κB was modulated by C. burnetii 
during infection, NF-κB activation was assayed via detection of p65 phosphorylation 
[275].  Total protein from -CAM and +CAM uninfected (U) and C. burnetii infected (I) 
THP-1 cells at 72 hpi (mid-log phase).  Figure 4.1A is a representative immunoblot 
where monoclonal antibody to the activated (Serine 536 phosphorylated) form of NF-κB 
p65 was used to probe total protein blots.  β-actin levels were used to normalize protein 
sample loading prior to NF-κB p65 analysis.  Figure 4.1B clearly shows that host cell 
NF-κB is activated during infection and that C. burnetii protein synthesis modulates the 
level of this NF-κB activation.  Fold changes between samples were calculated by 
comparing the amount of signal within each band as a percentage of the total signal 
representing a relative quantitation of the NF-κB activation.  When compared to 
uninfected THP-1 cells, NF-κB p65 phosphorylated protein levels were observed to 
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increase ~10-fold in C. burnetii infected cells.  However, NF-κB activation levels are 
~20-fold higher in infected cells treated with CAM.  These data indicate that while C. 
burnetii infection induces NF-κB activation, bacterial protein synthesis is modulating the 
levels of this induction. 
C. burnetii modulates NF-κB activation temporally during its infectious cycle.  
To measure the dynamics of NF-κB activation throughout the course of C. burnetii 
infection in the presence and absence of CAM, we examined total protein samples as 
outlined in Table 4.1.  Our hypothesis was that the activation of NF-κB would respond 
directly to de novo bacterial protein synthesis depending on the stage of infection (early, 
mid, or late).  Figure 4.2A shows a representative western blot of NF-κB p65 
phosphorylated protein at various times PI (24, 48, 72, 96, 120, and 144 hpi) in the 
presence and absence of transient CAM treatment.  Again, β-actin was used as a loading 
control to normalize the protein samples.  Figure 4.2B illustrates the calculated fold 
changes between the six time points in the +CAM and –CAM experimental sets.  C. 
burnetii protein(s) are seen to suppress NF-κB activation at 24hpi.  Transient treatment 
with CAM (0-24h) produces a ~16 fold increase in NF-κB p65 phosphorylation levels 
during early infection compared to uninfected cells.  The data also reveal that C. burnetii 
infection of THP-1 cells induces NFκB activation during mid-infection (48-96h).  
Compared to 24 hpi levels of p65 phosphorylation, 48 hpi levels are significantly up-
regulated (P < 0.05) and continue to remain elevated until 96 hpi.  Transient application 
of CAM at 24 and 48hpi results in even higher levels of p65 phosphorylation at 48 and 
72hpi respectively.  Again suggesting that C. burnetii proteins are involved in the 
regulation of NF-κB activation.  Interestingly, application of CAM at 72hpi does not 
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change the phosphorylation levels of p65 at 96 hpi relative to infected -CAM cells.  
During late infection (120-144h), NFκB induction is reduced to lower levels and de novo 
C. burnetii protein synthesis does not appear involved in this decrease.  These results 
indicate that infection of THP-1 cells by C. burnetii involves modulation of NFκB 
activation via p65 phosphorylation in a temporal manner.  Furthermore, de novo C. 
burnetii protein synthesis causes a significant suppression of NF-κB activation during 
early and mid stage of the infection. 
C. burnetii infection does not modulate NF-κB Activation via the Non-
Canonical pathway.  Results from our previous experiments show the involvement of 
p65 in NF-κB activation.  NF-κB transcription factors are typically activated by either the 
canonical, non-canonical, or IKK independent (Atypical) signaling pathways.  Canonical 
and atypical pathways signal via NF-κB p65 activation, while the non-canonical pathway 
signals by NF-κB p52 activation.  Formation of active p52 occurs via proteolytic 
processing of the p100 (precursor) during NF-κB non-canonical pathway signaling.  In 
order to determine the specific NF-κB signaling pathway(s) modulated by C. burnetii, we 
analyzed the role of non-canonical pathway in NF-κB activation over the course of 
infection.  Western blot analysis on total protein samples was carried out to detect NF-κB 
p100/p52 over the course of C. burnetii infectious cycle.  Figure 4.3A shows a western 
blot analysis of NF-κB p100/p52 at various times PI as outlined in Table 4.1.  Protein 
samples were first normalized to human β-actin and subsequently used to detect NF-κB 
activation.  CD 40 induced THP-1 cells were used as positive control.  Fold changes in 
protein expression levels are shown in Figure 4.3B and C respectively. Expression 
changes were calculated using signal intensities of both NF-κB p100 and p52.  Both 
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Figure 4.3B and C clearly demonstrate that C. burnetii does not appear to modulate host 
cell NF-κB p100 and p52 levels over the course of infection in the presence and absence 
of bacterial protein synthesis.  When compared to C. burnetii infected cells at 24hpi, NF-
κB p100 expression levels remain relatively constant at various times PI. Addition of 
CAM does not affect  p100 expression.  On the other hand, p52 levels are barely 
detectable and do not change in both –CAM and +CAM experimental sets (Figure 4.3 C).  
Together, these data reveal that NF-κB activation in infected host cells does not involve 
the non-canonical NF-κB signaling pathway. 
Discussion 
The NF-κB signaling pathway plays a crucial role in regulating pro-inflammatory 
immune response, cell death/apoptosis, and cell proliferation in a human host [262, 277].  
Pathogenic microorganisms induce NF-κB activation by triggering PRRs (e.g. TLRs and 
NLRs), which are expressed on macrophages, DCs and mucosal epithelial cells [22, 278]. 
NF-κB activation typically induces the expression of a variety of genes involved with the 
immune response [278-279].  These include pro-inflammatory cytokines, chemokines, 
and adhesion molecules which regulate recruitment and trafficking of immune cells to the 
site of infection [22, 278].  NF-κB activation increase the transcription of genes (e.g. 
defensins) which have direct microbicidal activity [278].  Enzymes which generate 
reactive intermediates are also induced [278].  NF-κB acts as a major molecular link 
between the launch of innate and adaptive immune responses by facilitating T cell 
activation via induction of MHC proteins and CD80/86 in antigen-presenting cells [278].  
B cell differentiation is usually stimulated by NF-κB activation as well [278].  
Additionally, NF-κB activation plays a critical role in the expression of anti-apoptotic 
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proteins (e.g. c-IAP-1/2, AI, Bcl-2 and Bcl-XL) [278-279].  Regulation of cell-cycle 
regulator cyclin D1, which increases cellular survival and proliferation is also dependent 
on NF-κB activation [278]. 
Interestingly, pathogenic microorganisms harbor unique strategies to directly 
interfere with NF-κB activation and its signaling [22].  Bacteria modulate the NF-κB 
signaling pathway (activation or inhibition) according to the requirement of their life 
cycle [22, 279].  Studies on C.  burnetii‟s closest phylogenetic neighbor, Legionella 
pneumophila, reveal that the bacteria induce a biphasic pattern of NF-κB activation in 
human epithelial cells [281].  A short term activation during early infection (< 8 hpi) is 
followed by a decrease in activation, which is then followed by a long term induction of 
NF-κB later in infection [281].  However, it is still unclear if the first wave of NF-κB 
activation is actively suppressed by L. pneumophila [281].  Numerous bacterial 
pathogens appear to produce effector proteins that interfere with host cell NF-κB 
signaling.  Bacterial modulators act both directly or indirectly on the NF-κB signaling 
pathway to elicit an effect advantageous to the pathogen [279].  Pathogens like Shigella 
flexneri and Yersinia spp. use their respective Type III effector proteins OspG and 
YopP/J to prevent IκB degradation, thereby keeping NF-κB inactive in the host cell 
cytoplasm [22].  On the other hand, activation of NF-κB protects several intracellular 
pathogens including Mycobacterium tuberculosis [282], Bartonella henselae [283], 
Chlamydia pneumonia [284], Rickettsia rickettsii [285], and Legionella pneumophila 
[281, 286] from cell death. 
 Here, we have built on our earlier finding that C. burnetii proteins modulate the 
mRNA abundance of NF-κB mediated cytokine genes (IL8, CCL2, CXCL1, and SPP1) 
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during infection [271].  The findings of our study clearly demonstrate that infection with 
C. burnetii induces host cell NF-κB activation.  In addition, this induction level is 
effectively modulated by de novo C. burnetii protein synthesis.  Figure 4.1 shows that 
host cell NF-κB activation is induced ~10-fold in C. burnetii infected THP-1 cells in 
comparison to uninfected cells.  However, this NF-κB activation is further induced to 
~20-fold when infected cells are transiently treated with CAM.  This increased NF-κB 
activation in the presence of transient CAM treatment coincides with our findings that the 
mRNA of some NF-κB mediated pro-inflammatory cytokines (IL8, CCL2, CXCL1, and 
SPP1) also increases in C. burnetii infections of THP-1 cells when bacterial protein 
synthesis is inhibited.  This suggests that while NF-κB is activated by C. burnetii 
infection, bacterial proteins modulate the level of this induction.  
 NF-κB activation is also associated with anti-apoptosis [262, 277].  Studies 
analyzing the effect of C. burnetii infection on host cell apoptosis show that bacterial 
protein synthesis inhibits cell death by preventing cytochrome C release from the 
mitochondria [20] and by activating host cell pro-survival kinases Akt and Erk1/2 [21].  
Antiapoptotic genes c-iap2 and A1/bfl-1 are also up-regulated in C. burnetii infected cells 
[19].  Both c-iap2 and A1/bfl-1 are positively regulated via the NF-κB pathway [19].  
Together, these studies suggest that two opposing effects of NF-κB activation could be 
occurring in C. burnetii infected cells:  Some level of NF-κB activation is required to 
suppress apoptosis, which is beneficial for the pathogen, while too much NF-κB 
activation would substantially induce host expression of pro-inflammatory cytokines.  
However, the host and bacterial factors involved with C. burnetii mediated NF-κB 
modulation remain elusive. 
 
 89 
 New insights can be obtained from our temporal analysis of NF-κB activation 
during infection (Figure 4.2.  Suppression of NF-κB activation during the first 24hpi may 
be linked to SCV to LCV morphogenesis or bacterial lag phase [172].  It appears that the 
bacterium employs unknown mechanisms to protect itself from pro-inflammatory 
mediators of innate inmmune response during early infection.  These unknown 
mechanisms seems to employ C. burnetii  proteins which might be directly or indirectly 
involved with this suppression as transient application of CAM induces a ~16-fold 
increase in NF-κB activation at 24 hpi.  During the exponential phase of C. burnetii, i.e 
between 24-96 hpi [172], NF-κB activation is induced by ~12-fold (48 hpi) in infected 
cells relative to infected cells at 24 hpi and remains relatively constant till 96 hpi (Figure 
4.2).  This is a crucial period in C. burnetii‟s life cycle, where bacterial growth can persist 
via NF-κB mediated anti-apoptotic effects [19].  It appears that induction of NF-κB 
activation ensures the integrity of infected cell during bacterial log growth.  This pattern 
of NF-κB activation observed in C. burnetii infected cells is similar to L. pneumophila 
mediated NF-κB activation in human epithelial cells and macrophages [281].  Our results 
support findings from other studies which indicate that both phase I and phase II C. 
burnetii induce antiapoptotic host cell activity during this growth period (48 hpi), leading 
to reduced caspase processing and PARP cleavage in monocytes and macrophages [19].  
However, it appears that C. burnetii is carrying out a balancing act by prohibiting NF-κB 
activation beyond a certain level, indicated by the observation that transient treatment 
with CAM at 24 and 48 hpi increases NF-κB activation levels by several fold (Figure 
4.2).  This indicates that C. burnetii proteins are playing a crucial role in controlling over 
production of pro-inflammatory cytokines while allowing the anti-apoptotic activity 
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necessary for survival.  During late infection (between 96-144hpi) there is drop in host 
cell NF-κB activation and C. burnetii‟s proteins do not affect this reduction.  This 
coincides with C. burnetii LCV to SCV morphogenesis [172].  We are currently pursuing 
experiments to determine whether induction of host cell NF-κB activation is an absolute 
requirement for C. burnetii survival and growth. 
 Finally, we have sought to determine whether more than one of the NF-κB 
signaling pathways (canonical, non-canonical, or atypical) [262] is being targeted by C. 
burnetii over the course of infection.  In Figure 4.2 we defined the temporal modulation 
of host cell NF-κB activation via p65 phosphorylation.  Involvement of p65 
phosphorylation suggests that C. burnetii infection of THP-1 cells induces NF-κB 
activation by signaling through either canonical or IKK-independent pathways.  Figure 
4.3 shows that C. burnetii infection of  THP-1 cells does not induce the non-cannonical 
NF-κB signaling pathway in the absence or presence of CAM over the course of 
infection.  Therefore, it is likely that C. burnetii proteins are interfering with either the 
canonical or atypical pathways, as evidenced by P65 phosphorylation, and not targeting 
the non-canonical signaling pathway (P100/p52) to modulate NF-κB activation in 
infected cells.  Identifying the C. burnetii infection associated NF-κB pathway(s) 
modulated during infection is aiding in the design of experiments to define the specific 
molecular mechanisms modulated by C. burnetii during infection. 
 In summary, we have demonstrated that C. burnetii infection induces NF-κB 
activation in THP-1 cells via p65 phosphorylation.  Additionally, de novo C. burnetii 
protein synthesis is able to modulate this NF-κB activation during infection.  Induction of 
NF-κB activation is temporal in C. burnetii infected cells, with bacterial proteins 
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suppressing NF-kB activation early in infection.  NF-κB activation levels increase during 
logarithmic phase but bacterial proteins via yet unknown mechanisms modulate the levels 
of this activation.  Interestingly during late infection, a decline of NF-κB activation is 
observed and this drop in activation levels is independent of bacterial protein synthesis.  
In addition, the non-canonical pathway of NF-κB signaling is not induced or modulated 













Table  4.1.  Temporal analysis of NF-κB activation in C. burnetii infected THP-1 cells. 
 
a
 - Times PI when fresh media with 10 μg/ml CAM (I + CAM)  or without CAM (I-
CAM)  was added  to C. burnetii infected host cells. 
b
 - Time points in hrs PI when cells were harvested for total protein extraction and 






Figure 4.1.  Immunoblot analysis of C. burnetii modulation of host-cell NFκB 
activation.  A. Top panel was probed with antibody to phosphorylated p65. Lower panel 
was probed with antibody to β-actin.  Uninfected without CAM (U-CAM). Uninfected 
with CAM (U+CAM). Infected without CAM (I-CAM). Infected with CAM (I+CAM).  
Time of sample collection is indicated above.  B.  Difference in phosphorylated p65 
protein levels relative to normalized β-actin.  The Y-axis represents fold changes in 
phoshorylated protein expression while X axis shows the conditions under which protein 
expression was observed. The results represent the mean of three independent 
experiments. Error bars represent +/- SD. Statistically significant differences (* P= 
<0.001) between the mean values among the samples were measured using One Way 
Repeated Measures Analysis of Variance and a Pairwise Multiple Comparison Procedure 




Figure 4.2: Analysis of NFκB activation in C. burnetii infected cells throughout the 
infectious cycle. A. Representative Western blot showing NF-κB activation over the time 
course of C burnetii infection. Top panel shows NFκB p65 phosphorylation levels which 
was probed with a monoclonal antibody against phosphorylated p65 (Ser 536) of human 
origin. The bottom panel shows human β-actin expression. Time in hpi at which each 
untreated (I-CAM) and CAM treated (I+CAM) C. burnetii infected cells was harvested is 
indicated as above. B. Fold change of NFκB p65 phosphorylation  vs time in the presence 
and absence of CAM. Results of densitometric analysis (Image J) are means ±S.E.M. of 
three different experiments. Statistical differences were calculated using T test for paired 
samples. * signifies P<0.05 of I-CAM samples compared to 24 h. ** signifies P<0.05 




Figure 4.3: Western blot analysis of NFκB p100 and p52 expression over the time 
course of C. burnetii infection. A.  A reprsentative western blot showing time course 
expression of p100 and p52 proteins in CAM treated and untreated C. burnetii infected 
cells.  Blots were probed with a polyclonal rabbit antibody against NFκB (p100/p52) of 
human origin (Top and middle panel).  The bottom panel shows normalized human β-
actin . CAM treated and untreated cells were used as negative controls while CD40 
treated THP-1 cells to detect p52 (positive control).  Each time point for sample 
collection is indicated as above. B.  Results of densitometric analysis showing means 
±S.E.M. (fold change) of three biological experiments. C.  Fold changes of NFκB2 p52 
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The zoonotic disease, Q fever, is caused by the gram-negative intracellular bacterium, 
Coxiella burnetii.  While normally transmitted during exposure to infectious aerosols, C. 
burnetii is also found in arthropod vectors.  In the environment, ticks are thought to play 
a crucial role in bacterial maintenance and transmission by infecting various mammalian 
species.  However, the nature of the pathogen-tick relationship is not well defined.  To 
determine C. burnetii’s interactions with a cultured tick cell line, we introduced purified 
C. burnetii NMII into Ixodes scapularis-derived IDE8 cells and assayed for bacterial 
presence, replication, gene expression, and subsequent infectivity for mammalian cells.  
Tick cells were harvested at 24 hrs, 72 hrs, 7 days and 11 days post infection (PI).  C. 
burnetii uptake and subsequent replication was demonstrated by indirect 
immunofluorescence assay (IFA), electron microscopy, and real-time PCR.  Using a 
genome equivalent multiplicity of infection (MOI) of 30, 30-40% of exposed cells were 
seen to have small, rounded, vacuoles at 72 hrs PI.  While at 7 and 11 days PI, 60-70% of 
cells contained enlarged vacuoles harboring large numbers of bacteria.  qPCR analysis of 
total genomic DNA confirmed that C. burnetii genome numbers increased significantly 
from 24 hrs to 11days PI.  The expression of C. burnetii type four secretion system 
homologs at 7 days PI was demonstrated by RT-PCR.  Finally, IFA demonstrated that C. 
burnetii propagated within IDE8 cells were infectious for mammalian cells.  These 
studies demonstrate the utility of cultured tick cell lines as a model to investigate C. 





Q fever is a zoonotic disease found throughout the world, with the exception of 
New Zealand [287-288].  The disease is caused by the Gram-negative intracellular 
bacterial pathogen Coxiella burnetii.  Human infection occurs mainly through inhalation 
of contaminated particulates shed from infected goats, sheep, and cattle [48, 80].  
Transmission to animals and humans is facilitated by the ability of C. burnetii to survive 
for extended periods in a spore-like state on objects contaminated with infected tick 
feces, in water, and in soil [165].  Additionally, wild and domestic mammals, birds, and 
ticks act as reservoirs for the bacterium[4, 80].  C. burnetii infections are usually not 
clinically apparent in animals, however acute and chronic infection can lead to abortion 
in sheep and goats, and low birth weights and infertility in cattle[289].  Since ticks are a 
reservoir, it is thought that they act as vectors in the transmission of C. burnetii amongst 
animals [47, 74, 80] as well as maintaining the pathogen in the environment.  Early 
investigations indicate that C. burnetii may replicate in the middle gut or stomach of ticks 
and subsequently be excreted in the feces [290].  Moreover, studies indicate that 
transovarial and transstadial transmission of C. burnetii may occur in Hyalomma 
asiaticum, Hyalomma lusitanicum and Dermacentor marginatus [291-293].  While there 
is evidence that C. burnetii is able to replicate in crude primary tick cell cultures [49], 
recently established continuous tick cell lines have not been employed to study the host 
cell-pathogen interactions of C. burnetii and these vectors. 
Blood feeding Ixodid ticks (subphylum Chelicerata; class Arachnida; subclass 
Acari; family Ixodidae) are known to transmit a variety of bacterial, rickettsial, viral, and 
protozoan diseases [294].  Ixodid ticks have recently been shown to harbor Coxiella spp. 
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and Coxiella-like pathogens in the wild [295].  Due to the efficiency of Ixodes spp. ticks 
as vectors of pathogens and their worldwide distribution, we have chosen an Ixodes 
scapularis-derived cell line (IDE8) to investigate as an in vitro model for studying the 
tick-pathogen cellular interactions of C. burnetii.  This cell line has been used to 
successfully propagate multiple tick-borne pathogens including Anaplasma 
phagocytophilum, A. marginale, Ehrlichia canis, E. ruminantium, Borrelia spp. and 
Rickettsia spp. [296].  In the current study, we sought to determine C. burnetii’s 
infectivity, growth rate, gene expression as well as its ability to reinfect mammalian cells 
after growth in cultured tick cells.  Using the indirect fluorescent antibody (IFA) 
microscopy assay, electron microscopy (EM), quantitative PCR (qPCR), and reverse 
transcriptase-PCR (RT-PCR) we determined the ability of C. burnetii to invade and 
replicate within the IDE8 tick cell line, expression levels of genes of the Type Four 
Secretion System (T4SS) within tick cells and the ability of tick cell derived C. burnetii 
to invade mammalian cells. 
Materials and Methods 
Bacterial cultivation and purification.  Coxiella burnetii Nine Mile Phase II 
Clone 4 (NMII) was propagated in African green monkey kidney (Vero) cells in RPMI 
1640 medium, 5% fetal bovine serum (FBS) at 37°C in an atmosphere of 5% CO2, and 
the Small Cell Variant  form of the organism was isolated as previously described [172].  
The SCVs were resuspended in SPG buffer (0.7 M sucrose, 3.7 mM KH2PO4, 6.0 mM 
K2HPO4, 0.15 M KCl, 5.0 mM glutamic acid, pH 7.4) and stored at -80°C.  C. burnetii 
genome equivalents were calculated using qPCR [297]. 
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 Tissue culture cells:  Uninfected Vero cells were propagated as described in 
medium containing 20 µg/ml gentamicin.  The medium was exchanged with fresh RPMI 
1640, 5% FBS without antibiotics two hours prior to bacterial infection.  The tick cell 
line IDE8 (ATCC CRL 11973), derived from embryos of Ixodes scapularis and 
maintained in continuous passage for several years, was maintained in a modified 
Liebovitz‟s L15 medium at 34°C following the procedures of Munderloh et al [298].  
Cultures were washed with antibiotic-free media prior to C. burnetii infections. 
Infection of IDE8 tick cells:  The optimal C. burnetii multiplicity of infection 
(MOI, based on genome equivalents) for IDE8 cells was empirically determine (data not 
shown).  Thereafter, 25cm
2
 flasks containing 1x10
7
 IDE8 cells were infected with C. 
burnetii NMII at a genome equivalent MOI of 30 in 2 mls of L15 medium at 34°C for 4 
hours.  The flask volume was then brought up to a total of 5 mls with L15 media.  
Infected cells were incubated at 34°C with culture flask caps closed.  Media was replaced 
every 24-48 hrs as needed. 
IDE8 cell sample harvest.  The 25cm
2
 flasks containing 1x10
7
 IDE8 cells were 
divided into five sections.  One section of the flask was harvested by scraping just prior 
to infection (uninfected), and 24, 72, 168 (7 days), and 264 hrs (11 days) post infection 
(PI).  Media was removed prior to each sampling and replaced immediately afterwards, 
and flasks returned to incubation.  Parallel aliquots of infected cells from each time point 
were (i) seeded in 24-well plastic tissue culture plates for 3-4 hours at 34°C to allow for 
re-attachment, and then fixed with a 4% paraformaldehyde, Tween 20 (0.05%) PBS 
solution, (ii) fixed to glass slides using a cytospin centrifuge followed by fixation for 10 
minutes using ice cold methanol, and (iii) centrifuged and the total genomic DNA 
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isolated using the Genomic Isolation Kit (Promega, Madison, WI).  A minimum of three 
biological samples were isolated for each condition and time point. 
Indirect Immunofluorescence antibody assay:  The 24–well plate seeded and 
cytospun samples were analyzed by IFA microscopy using rabbit polyclonal antibody 
against whole-killed C. burnetii NMII followed by an Alexa-fluor 488 tagged goat anti-
rabbit IgG (Molecular Probes, Eugene, OR).  Fluorescent images were captured at 400X 
magnification using a Nikon eclipse TE-2000 S inverted microscope equipped with a 
Nikon DS-Fi1 digital camera. 
Vero cells seeded on 24-well tissue culture plates were inoculated with C. burnetii 
isolated from 7 day PI IDE8 cell lysates.  Lysates were created by scraping C. burnetii 
infected IDE8 cells into PBS, freeze thawing the cells twice at -80°C followed by 
repeatedly passing the thawed cells through a 26.5-gauge needle.  C. burnetii were 
separated from cell debris by differential centrifugation, and resuspended in RPMI 1640 
medium, 5% fetal bovine serum (FBS), which was used to inoculate the Vero cells within 
24-well culture plates. Cultures were grown at 37°C in an atmosphere of 5% CO2, for 72 
hours, then fixed to the culture plates using methanol.  IFA microscopy analysis was 
performed directly in the culture plates as described above. 









 genomes/sample well) were used to generate a standard 
quantitative curve in each experiment. Estimation of C. burnetii genome equivalents in 
infected IDE8 cell samples was accomplished using qPCR and the SYBR Green Master 
Mix kit (Applied Biosystems) in an Applied Biosystems 7500 real-time cycler, with 
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forward [f] and reverse [r] primers CB594 -5‟CGCTTCATGAATTAGCAGCA–3‟[f] and 
CB595 -5‟TGCAGTCAAACGGTTCTTCA-3‟[r].  These primers target the C. burnetii 
icmW gene (GenBank accession no. AF318146).  Briefly, the reaction mixture contained 
0.3 µM of each primer, and 10ng of sample template DNA in a total volume of 15µl.  
The resulting fluorescent plots were analyzed and estimated numbers of C. burnetii 
genomes in the experimental samples were determined based on the standard curve.  An 
increase in genome equivalents was observed relative to infected IDE8 cells collected 24 
hours PI.  A minimum of three biological and three technical samples were used in the 
analysis of each time point. 
RNA isolation and quality control.  One half of a 25cm
2
 flask containing 
infected IDE8 cells was scraped at 7 days PI and cells were pelleted by centrifugation.  
Total RNA was then harvested using Tri Reagent (Ambion, San Antonio, TX) following 
the manufacturer‟s recommendations.  All RNA samples were DNase treated to remove 
contaminating DNA with RQ1 DNase (Promega, Madison, WI) and confirmed DNA-free 
by PCR prior to RNA analysis assays. 
Reverse Transcriptase-PCR (RT-PCR) analysis.  RT-PCR analysis was carried 
out using the Access Quick RT-PCR Kit (Promega, Madison, WI) and total RNA isolated 
from C. burnetii infected IDE8 cells following the manufacturer‟s directions.  Primers 
CB40-5‟ATGCCAGATCTGTCGC-3‟[f] and CB41-5‟TAAACCACCTTCCTCAAGAG-
3‟[r] (icmW), CB70-5‟ATGATTCTTTTGGAGTCTTCC-3‟[f] and CB71-
5‟TTGTTTGGACCCCTTAAAGGTG-3‟[r] (icmV), and CB703-
5‟ATTGGGGCCAGTATCATTCC-3‟[f] and CB696-
5‟ATGGAGTGTGCGGATTTGAT-3‟[r] (dotH), were used in RT-PCR analysis. 
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Electron microscope analysis.  One half of a 25cm
2
 flask containing infected 
IDE8 cells was scraped at 7 days PI and cells were pelleted by centrifugation.  The C. 
burnetii infected IDE8 cells were fixed with 2.5% paraformaldehyde (v/v)/2.5% 
glutaraldehyde (v/v) for transmission electron microscope (EM) analysis as previously 
described (Morgan, Luedtke et al. 2010) . The Imaging Facility in the Department of 
Molecular Microbiology Center for Infectious Disease Research, Washington University, 
St. Louis, MO, performed the subsequent sample processing and transmission EM 
analyses following published techniques [299]. 
Results 
C. burnetii infection of IDE8 tick cells:  To determine whether C. burnetii 
infects IDE8 cells, we used an approximate genome equivalent MOI of 30. The infected 
cells were cytospun to a microscope slide followed by methanol fixation and IFA.  These 
analyses indicate that C. burnetii containing vacuoles are present by 72 hrs PI and large, 
spacious, immunostained C. burnetii vacuoles were prominent by 7 days PI (data not 
shown).  Although this indicated that C. burnetii were infecting IDE8 cells and 
replicating within them, the cytospin centrifugation method causes distortion and/or 
disruption of infected cells resulting in dispersion of many of the bacteria. 
In order to observe infected IDE8 cells that are physiologically intact, an 
alternative method was employed where the tick cells were re-seeded to 24-well tissue 
culture plates and allowed to adhere prior to fixation and IFA analysis.  Figure 5.1A 
shows that after 72h PI approximately 30-40% of infected cells had small, rounded, 
vacuoles and at 168 hrs (7 days) PI, swollen enlarged vacuoles containing large numbers 
 
 104 
of bacteria were present.  By 264 hrs (11 days) PI, the infected IDE8 cells had large 
fragile vacuoles such that intact infected cells could not be transferred from larger flasks 
to 24-well culture plates for microscopy analysis without rupturing the cells. 
To determine whether C. burnetii were growing within membrane bound 
parasitophorous vacuoles (PVs), EM was performed on infected IDE8 cells fixed at 7 
days PI (Figure 5.1B).  EM micrographs indicate that C. burnetii is replicating in a 
membrane bound compartment (Figure 5.1B, left panel) and that both replicative large 
cell variants (LCV) and environmentally stable small cell variant (SCV) forms of the 
bacteria appear to be present within the vacuole (Figure 5.1B arrows and arrowheads, 
respectively) at 7 days PI.  Combined, these experiments demonstrate that C. burnetii can 
be internalized, survive and grow within IDE8 tick cells in vitro.  The appearance of 
spacious vacuoles at the beginning of what might be thought of as the exponential growth 
phase (72 hrs PI) is similar to that seen in C. burnetii infection of cultured mammalian 
cells [172]. 
C. burnetii genome numbers increase after an extended lag phase:  In an effort 
to quantitate the growth characteristics of C. burnetii NMII in IDE8 tick cells, we 
estimated the number of C. burnetii genomes during the course of infection using qPCR.  
Using primers designed to the C. burnetii icmW homolog, and 24 hrs PI as a base line, C. 
burnetii genome equivalents were observed to decrease slightly between 24 and 72 hrs 
PI, although the decrease was not statistically significant (p<0.05). This was followed by 
a 3.10 and 17.83 fold increase at 7 , and 11 days PI (Figure 5.2), respectively.  After a 
lag, C. burnetii double every ten hours in mammalian cell models [172, 300].  Using our 
data to calculate the replication rate of C. burnetii in the IDE8 cells, a doubling time of 
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nearly forty hours can be derived over the entire time period.  However, if the calculation 
is made following the approximately 72 hr lag phase, C. burnetii genomes double every 
10.87 hrs (Figure 5.2) in the IDE8 cells.  This rate is very similar to the 10.2 hr (qPCR 
assay) rate found during the exponential phase of C. burnetii growth in mammalian cells 
following a 48 hr lag phase [172]. 
Expression of the C. burnetii T4SS during infection of IDE8 cells.  Secretion 
systems have been shown to be crucial for the delivery of effector proteins in a number of 
bacterial pathogens.  In particular, the type three secretion system is required for the 
virulence of bacteria including E. coli, Shigella, and Salmonella spp. [301].  C. burnetii 
possesses T4SS homologs, a system which has been shown to be required for virulence in 
its closely related neighbor, Legionella pneumophila [302-304].  C. burnetii T4SS 
homologs are expressed at the RNA and protein level during infection of mammalian 
cells in culture [172, 205, 207-208].  To determine whether this virulence determinant is 
expressed by C. burnetii during infection of IDE8 cells, RT-PCR was used to analyze 
total RNA isolated from infected cells 7 days PI (Figure 5.3).  Amplification products 
following RT-PCR clearly demonstrate that icmW, icmV and dotH are expressed by the 
bacterium during infection of the IDE8 cell line. 
IDE8 derived C. burnetii infectivity for mammalian cells.  To determine 
whether the C. burnetii surviving within IDE8 cells were infectious for mammalian cells, 
IFA microscopy analysis was performed on Vero cells that were inoculated with lysates 
harvested from C. burnetii infected IDE8 cells 7 days PI.  Figure 5.4 shows an IFA of 
Vero cells infected with IDE8 derived C. burnetii.  In this qualitative analysis, it is 
evident that the C. burnetii growing within IDE8 cells are infectious for mammalian 
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cells.  Large PVs containing multiple bacteria are indicated by the large, green 
fluorescing vacuoles present within the Vero cells (Figure 5.4).  This finding indicates 
that the C. burnetii growing within tick cells are readily infectious for mammalian cells, 
increasing the likelihood that tick-borne exposure to the pathogen could lead to disease. 
Discussion 
Since the earliest studies of C. burnetii, it has been known that this pathogen has 
an association with arthropod vectors [62, 76].  However, an understanding of whether C. 
burnetii is passively carried in ticks or it is amplified by replication within the tick is not 
clear.  Additionally, it has been demonstrated that C. burnetii can grow in a myriad of 
mammalian cell lines [19, 305-307], yet its ability to invade, replicate, and produce 
infectious progeny in tick cell lines had not been reported. 
Our findings indicate that C. burnetii readily infects cultured IDE8 cells.  
Quantitative PCR of the icmW gene indicates C. burnetii grown in IDE8 cells undergoes 
a prolonged lag phase before replication begins relative to growth in mammalian cells 
[172].  When replication does begin, C. burnetii’s doubling time in IDE8 cells appears to 
approach the approximately 10 hrs observed in mammalian cells.  These findings suggest 
a period of adjustment may be required for successful growth.  It may be that the 
organism has to adjust to the lower temperature (34°C) of IDE8 cell culture.  It could also 
be hypothesized that the bacterium has to adjust to a substantially different host cell 
environment relative to in vitro growth in a mammalian cell line.  Both factors may 
influence C. burnetii’s replication during early infection of these tick cells.  Interestingly, 
while C. burnetii genome numbers remained relatively constant between 24 and 72 hrs of 
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infection (Figure 5.2), vacuoles with appreciable numbers of C. burnetii are evident in 72 
hrs PI IFA analyses (Figure 5.1).  Although difficult to appreciate in the low light 
fluorescent images (Figure 5.1), a large number of free, or single, bacteria were observed 
24 after C. burnetii infection of IDE8 cells, suggesting that many of the bacteria used to 
initiate an infection did not cause a productive infection within a given cell.  We 
speculate that this is the result of overestimation of the MOI due to the inability of the 
qPCR assay to discriminate between DNA from viable and non-viable bacteria, or that 
the IDE8 cells were capable of ingesting and killing a portion of the bacteria.  In either 
case, the bacteria that invaded and survived within the IDE8 cells had formed visible 
vacuoles by 72 hrs PI (Figure 5.1). 
The ability of facultative and obligate intracellular pathogens to subvert host cell 
processes is crucial to their survival. Secretion systems are one of the primary means by 
which pathogens interact with the host.  Our evidence that C. burnetii is expressing RNA 
for the production of a T4SS during infection of IDE8 cells (Figure 5.3) leads us to 
hypothesize that the pathogen is interacting with the tick cells and are likely manipulating 
the host cell response, as in mammalian cells [18].  In mammalian cells, the expression of 
T4SS homologs has been shown at the RNA level throughout infection and that the T4SS 
machinery is localized to the poles of the bacterial cell [172, 205, 207-208].  Moreover, it 
is likely that the C. burnetii T4SS is crucial to the pathogens ability to subvert cellular 
pathways for its own benefit. 
Ultimately, C. burnetii’s ability to infect a mammalian host after replication 
within a tick vector makes ticks a viable and crucial environmental reservoir of this 
pathogen.  Our demonstration that C. burnetii isolated from IDE8 cells could readily 
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infect cultured Vero cells (Figure 5.4) would indicate that the C. burnetii propagated 
within a tick would be capable of causing disease in humans and other mammals.  In 
addition, the production of environmentally stable SCV forms of the pathogen would 
enable a tick vector to shed infectious particles with the ability to cause disease long after 
they enter the environment. 
The results of these experiments show that C. burnetii capable of infecting 
mammalian cells are produced in IDE8 tick cells after an extended lag phase.  Further, 
we demonstrate that C. burnetii expresses homologs of a suggested virulence determinant 
during infection of the IDE8 cultured cells.  These findings demonstrate that cultured tick 
cells represent a viable in vitro model to study the pathogens cellular interactions with 
tick cells in comparison to those found in mammalian cells while expanding our 
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Fig. 5.1:  IFA of Coxiella burnetii NMII infection of IDE8 cells.  (A) Left panel, DAPI 
stained cells. Middle panel, Alexa-488 labeling of C. burnetii. Right panel, merge of left 
and middle panels. Time of fixation PI, are indicated at the left of each corresponding 
row.  (B) EM micrograph of C. burnetii infected IDE8 cells fixed at 7 days PI.  Arrows 
indicate C. burnetii large cell variants. Arrowheads indicate C. burnetii small cell 






Fig. 5.2:  C. burnetii genome levels during infection of IDE8 cells.  Fold changes in 
genome numbers relative to 24 hours PI. An equal amount of total genomic DNA from 
each sample was analyzed by qPCR. The time (in hours and days) PI when DNA was 
harvested is indicated below the X-axis.  Results represent the mean of three biological 
samples with no fewer than three technical replicates of each sample.  Standard error bars 










Fig. 5.3:  RT-PCR detection of C. burnetii T4BSS transcripts, icmW, icmV, and dotH 
during infection of IDE8 cells.  Total RNA template was isolated at 7 days PI from C. 
burnetii infected IDE8 cells.  L, 100 bp DNA ladder.  +RT, with reverse transcriptase.  –








Fig. 5.4:  IFA of IDE8 derived Coxiella burnetii NMII infecting Vero cells.  Left 
panel, DAPI stained cells.  Middle panel, Alexa-488 labeling of C. burnetii.  Right panel, 






SUMMARY REVIEW OF: ANALYSIS OF COXIELLA BURNETII 







Coxiella burnetii is a pleomorphic obligate intracellular bacterium that has two 
distinct stages in its life cycle.  The metabolically active/replicative form is called the 
large cell variant (LCV) whereas the environmentally stable form is termed the small cell 
variant (SCV).  Goats, sheep, and cattle are the main reservoirs of C. burnetii‟s while 
ticks, birds, and wild and domestic mammals may also act as reservoirs in the 
environment.  Interestingly, ticks are thought to play a crucial role in the transfer of C. 
burnetii between wild and domestic animals.  Transmission to humans and animals 
primarily occurs due to the ability of SCVs to remain viable for prolonged periods in soil, 
water and on objects contaminated with tick feces.  Chronically infected animals shed 
bacteria in milk and urine [82, 308-309].  Although overt disease occurs infrequently in 
these animals, C. burnetii has a tropism for birthing (placenta, amniotic fluids) tissues 
and infection of these tissues can result in abortion [87, 310].  Birthing tissues  have been 
shown to harbor up to 10
9
 organisms per gram [80], which can be aerosolized, exposing 
other animals and/or humans.  Infection typically occurs via inhalation of the aerosolized 
bacteria and usually causes a self-limiting flu-like illness.  However, acute Q fever 
symptoms can range in severity from asymptomatic to debilitating [4].  Chronic Q fever 
usually manifests as endocarditis or hepatitis. 
During the course of an infection, C. burnetii invades a host cell, is trafficked to a 
vacuole resembling a mature phagosome, replicates within this environment avoiding 
cellular defenses, lyses the cell, encounters a new host and begins the process again.  
Protein synthesis by C. burnetii is required in the process of phagolysomal establishment 
and maintenance of a spacious parasitophorous vacuole (SPV) during bacterial growth.  
Interruption of bacterial protein synthesis results in SPV collapse, and eventual death of 
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the bacterium.  The asymptomatic nature of many C. burnetii exposures with subsequent 
chronic forms of disease highlight the immunomodulatory properties of this organism.  
These conditions demonstrate that C. burnetii actively manipulates host cell activites and 
evades host cell immune responses for its survival and growth.  The mechanisms that C. 
burnetii employs to interact with its host cell are a mystery yet represent crucial systems 
for subverting host cell defenses, acquiring specific host-derived molecules, and 
maintaining the PV until cell lysis occurs.  In an effort to identify host-cell pathways and 
processes that are specifically manipulated by C. burnetii during the course of infection, 
we have characterized the global expression of host cell mRNA following infection with 
C. burnetii Nine Mile Phase II strain and discovered host genes specifically modulated by 
de novo bacterial protein synthesis.  Additionally, we have also identified a major 
eukaryotic immune response signaling pathway regulated by C. burnetii during infection. 
It was our hypothesis that the expression of host cell genes would be changed by 
infection with C. burnetii NMII and that a subset of these genes would be in response to  
bacterial derived proteins.  Using microarray analysis, we compared RNA from THP-1 
cells; (i) uninfected versus C. burnetii NMII infected and (ii) uninfected versus C. 
burnetii NMII infected cells transiently inhibited with 10µg/ml of chloramphenicol.  
RNA from mid log (72hpi), infection was used to define expression differences between 
the treated and untreated array results.  Selected targets were later confirmed by real time 
RT-PCR.  Through our microarray studies we have generated two separate global mRNA 
expression profiles.  Analysis of C. burnetii infected (-CAM) and uninfected (-CAM) 
THP-1 cells revealed a gene summary list of 2557 genes which changed >0 fold.  In this 
analysis, the mRNA expression of 784 genes changed by at least 2 fold (significant 
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change).  On the other hand, the host transcriptional expression of C. burnetii infected 
(+CAM) and uninfected (+CAM) THP-1 cells revealed a gene summary list of 2584 
genes that changed >0 fold.  Examination of this data set generated a subset of 901 genes 
which changed significantly (>2 fold change).  Examination of differentially expressed 
genes in individual microarray data sets to detect the prominent host cell functions 
affected indicate involvement of the host cell immune response, cell migration, regulation 
of programmed cell death, intracellular signaling cascades, regulation of cell 
proliferation, and cytoskeletal organization. 
A cross comparison of –CAM and +CAM mRNA data sets (described in Chapter 
3) identified 36 host cell genes with significant (≥ 2 fold) gene expression differences 
across the data sets. Subsequent bio-informatic analysis used to categorize possible 
biological functions of these 36 genes showed that de novo C. burnetii protein synthesis 
regulates the immune response, cellular movement, cellular signaling, cellular 
proliferation, cell death, lipid metabolism, molecular transport, as well as vesicle 
trafficking and cytoskeletal organization of the host cell.  Prominent genes that  are 
suppressed during C. burnetii infection relative to transiently inhibited infections include 
IL8, CCL2, CXCL1, SPP1 (cytokines), BCL3, CTSB and CTSL1 (apoptosis), MTSS1, 
SMTN and PLEKHO1 (cytoskeleton organization), APOE, PLIN2 and FABP4 (lipid 
metabolism), and RAB20, SOD2, PSMA8, MSC, ZFP36L1, and RORA (Miscellaneous).  
Notable genes induced during C. burnetii infection include ITK, DUSP9 & SKP2 
(intracellular signaling), SOX11, HELLS and PGR (cell growth and proliferation) 
SLC22A6, CDH2, PSD4, ZNF573, CHMP5 and MRPL44 (Miscellaneous) and ANLN 
(cytoskeleton organization).  These findings indicate that C. burnetii proteins play a 
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major role in modulation of host cell functions and pathways during infection.  Of 
particular interest was a subset of immune signaling pro-inflammatory cytokine genes 
whose expression is lower in C. burnetii infections of THP-1 cells relative to parallel 
infections where bacterial protein synthesis was inhibited [271].  Cytokine genes are 
typically regulated through the NF-κB signaling pathway.  Therefore, we analyzed 
whether C. burnetii NMII infection of THP-1 cells induces NF-κB activation. 
Analysis of NF-κB activation was performed on (i) uninfected and C. burnetii 
NMII infected and (ii) uninfected and C. burnetii NMII infected cells transiently treated 
with 10µg/ml of chloramphenicol.  Results of western blots revealed that p65 
phosphorylation was induced ~10-fold in C. burnetii infected THP-1 cells (72hpi) 
compared to uninfected cells.  However, addition of CAM caused a further increase in 
phosphorylation levels of p65 to ~20- fold; suggesting that C. burnetii infection distinctly 
induces NF-κB activation yet the levels of this activation is modulated by bacterial 
protein synthesis.  Subsequently, we examined NF-κB activation in C. burnetii infected 
cells over the course of infection.  It was our hypothesis that activation of host cell NF-
κB will vary with the stage of infection (early, mid, or late) and respond directly to 
bacterial protein synthesis.  Western blot analysis demonstrates that induction of NF-κB 
activation in human THP-1 cells infected with C. burnetii is temporal in nature and levels 
of induction are modulated by bacterial proteins.  Relative NF-κB activation levels in C. 
burnetii infected cells were higher during mid infection (48-96 hpi) compared to early 
(24 hpi) and late (120-144 hpi) infection.  Moreover, de novo C. burnetii protein 
synthesis was observed to modulate the levels of p65 phosphorylation in C. burnetii 
infected THP-1 cells.  Analysis of the specific NF-κB pathway(s) targeted by C. burnetii 
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during infection revealed that the non-canonical pathway remains inactivated during 
infection both in the absence and presence of CAM.  NF-κB p100/p52 expression levels 
stayed relatively constant throughout the C. burnetii life cycle in THP-1 cells indicating 
that either the canonical or the atypical NF-κB signaling pathway is activated during C. 
burnetii infection. 
Together these findings illustrate that C. burnetii proteins induce specific gene 
expression changes in their host cell during infection and that this molecular control 
extends to modulation of the crucial NF-κB signaling pathway.  Figure 6.1 is a proposed 
model for the changes observed in the transcript levels of host cell genes during C. 
burnetii infection.  We propose that C. burnetii proteins modulate NF-κB activation, 
subsequently changing the transcript levels of genes (cytokines, apoptosis regulation, cell 
proliferation, and cytoskeletal modulation) in order to support bacterial survival and 
growth in the host.  Further studies investigating the specific pathway(s) and the 
molecular targets within each pathway is necessary to provide insight into the molecular 
mechanisms involved in C. burnetii mediated modulation of NF-κB activation during 
infection. Such studies will expand our knowledge of the molecular pathogen-host 
interactions of this unusual bacterium. 
Besides analyzing Coxiellae-monocyte cellular interactions, we have also 
investigated C. burnetii‟s ability to invade and replicate in a cultured tick cell line.  This 
study was performed in an effort to develop a Coxiellae-tick host cell model for 
comparative cellular and molecular interaction studies between tick and mammalian 
cells.  We demonstrated that C. burnetii readily infects Ixodes scapularis–derived IDE8 
cells, followed by a prolonged lag phase prior to the onset of replication.  However, after 
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replication is initiated, the doubling time of C. burnetii is ~10h, which is similar to that 
observed in mammalian cells.  In addition, RT-PCR demonstrated that C. burnetii T4BSS 
genes (icmW, icmV, and dotH) were expressed during infection of IDE8 cells.  Finally, 
indirect immunofluorescence assays demonstrated that the C. burnetii propagated within 
IDE8 cells was infectious for mammalian (Vero) cells.  These studies demonstrate the 
utility of cultured tick cell lines as a model to investigate C. burnetii’s molecular 




















Figure 6.1: Mechanism showing C. burnetii mediated modulation of host cell 
transcripts during infection. Unknown stimulus induces the phosphorylation (P), 
subsequent ubiquitination (U ) and proteosomal degradation of IκBs.  Associated p50/p65 
NF-κB dimers are released and translocate into the nucleus to bind and express host 
genes.  C. burnetii proteins modulate host cell NF-κB activation to regulate host cell gene 
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